<SEC-DOCUMENT>0001193125-20-313889.txt : 20201209
<SEC-HEADER>0001193125-20-313889.hdr.sgml : 20201209
<ACCEPTANCE-DATETIME>20201209165132
ACCESSION NUMBER:		0001193125-20-313889
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20201207
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20201209
DATE AS OF CHANGE:		20201209

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVS HEALTH Corp
		CENTRAL INDEX KEY:			0000064803
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				050494040
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01011
		FILM NUMBER:		201378353

	BUSINESS ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895
		BUSINESS PHONE:		4017651500

	MAIL ADDRESS:	
		STREET 1:		ONE CVS DR.
		CITY:			WOONSOCKET
		STATE:			RI
		ZIP:			02895

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CAREMARK CORP
		DATE OF NAME CHANGE:	20070509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS/CAREMARK CORP
		DATE OF NAME CHANGE:	20070322

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVS CORP
		DATE OF NAME CHANGE:	19970128
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d48081d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvs="http://CVS/20201207" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body>
 <div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2020-12-07_to_2020-12-07">CVS HEALTH Corp</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2020-12-07_to_2020-12-07">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2020-12-07_to_2020-12-07">0000064803</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cvs-20201207.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2020-12-07_to_2020-12-07"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000064803</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2020-12-07</xbrli:startDate> <xbrli:endDate>2020-12-07</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2020-12-07_to_2020-12-07">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): December 9, 2020 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2020-12-07_to_2020-12-07" format="ixt:datemonthdayyearen">December 7, 2020</ix:nonNumeric>)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="margin-top:0pt;margin-bottom:0pt;text-align:center">
<img src="g48081g1208231322691.jpg" alt="LOGO" /></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">CVS HEALTH CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2020-12-07_to_2020-12-07" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2020-12-07_to_2020-12-07">001-01011</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2020-12-07_to_2020-12-07">05-0494040</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2020-12-07_to_2020-12-07">One CVS Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2020-12-07_to_2020-12-07">Woonsocket</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2020-12-07_to_2020-12-07" format="ixt-sec:stateprovnameen">Rhode Island</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2020-12-07_to_2020-12-07">02895</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2020-12-07_to_2020-12-07">(401)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2020-12-07_to_2020-12-07">765-1500</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report: N/A</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2020-12-07_to_2020-12-07" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2020-12-07_to_2020-12-07" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2020-12-07_to_2020-12-07" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2020-12-07_to_2020-12-07" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2020-12-07_to_2020-12-07">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2020-12-07_to_2020-12-07">CVS</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2020-12-07_to_2020-12-07" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2020-12-07_to_2020-12-07" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Section&#160;8 - Other Events </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;7, 2020, CVS Health Corporation, a Delaware corporation (the &#8220;Company&#8221; or &#8220;CVS Health&#8221;), entered into an Underwriting Agreement (the &#8220;Underwriting Agreement&#8221;) with Barclays Capital Inc., Goldman Sachs&#160;&amp; Co. LLC and J.P. Morgan Securities LLC, as representatives of the several underwriters named in Schedule I thereto (collectively, the &#8220;Underwriters&#8221;), pursuant to which the Company agreed to issue and sell to the Underwriters $750,000,000 aggregate principal amount of the Company&#8217;s 1.300% Senior Notes due 2027 (the &#8220;2027 Notes&#8221;) and $1,250,000,000 aggregate principal amount of the Company&#8217;s 1.875% Senior Notes due 2031 (the &#8220;2031 Notes&#8221; and, together with the 2027 Notes, the &#8220;Notes&#8221;). The 2027 Notes represent a further issuance of the Company&#8217;s 1.300% Senior Notes due 2027 issued in an aggregate principal amount of $1,500,000,000 on August&#160;21, 2020 (the &#8220;Existing 2027 Notes&#8221;). Except as otherwise described in the prospectus supplement filed by the Company on December&#160;9, 2020, the 2027 Notes will have identical terms and will be treated as a single class with the Existing 2027 Notes. The Notes were offered pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3ASR,</span> File <span style="white-space:nowrap">No.&#160;333-238506,</span> dated May&#160;19, 2020 (the &#8220;Registration Statement&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The closing of the sale of the Notes is expected to occur on December&#160;16, 2020, subject to the satisfaction of customary closing conditions contained in the Underwriting Agreement. The net proceeds to the Company from the sale of the Notes, after deducting the Underwriters&#8217; discounts and the estimated offering expenses payable by the Company, are approximately $1,986,130,000. A copy of the Underwriting Agreement is filed as Exhibit 1.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated by reference into the Registration Statement. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold">Section</span><span style="font-weight:bold"></span><span style="font-weight:bold">&#160;9</span>&#160;&#8211;<span style="font-weight:bold">&#160;Financial Statements and Exhibits</span> </p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top" align="left">(d)</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="text-decoration:underline">Exhibits</span>. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The exhibits to this Current Report on Form <span style="white-space:nowrap">8-K</span> are as follows: </p> <p style="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">INDEX TO EXHIBITS </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d48081dex11.htm">Underwriting Agreement dated December&#160;7, 2020, among CVS Health Corporation and Barclays Capital Inc., Goldman Sachs&#160;&amp; Co. LLC and J.P. Morgan Securities LLC, as representatives of the several Underwriters named in Schedule I thereto. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />


<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"><span style="font-weight:bold">CVS HEALTH CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: December 9, 2020</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ Eva C. Boratto</span></p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Eva C. Boratto</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Executive Vice President and Chief Financial Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d48081dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">EXECUTION VERSION </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS HEALTH
CORPORATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$750,000,000 1.300% Senior Notes due 2027 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$1,250,000,000 1.875% Senior Notes due 2031 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Underwriting Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">December&nbsp;7, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As Representatives of the several Underwriters </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">named in <U>Schedule I</U> hereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Barclays
Capital Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">745 Seventh Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10019
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Goldman Sachs&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">200 West Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10282 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o J.P. Morgan Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10179 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">CVS Health Corporation, a
Delaware corporation (the &#147;<B>Company</B>&#148;), proposes to issue and sell $750,000,000 aggregate principal amount of its 1.300% Senior Notes due 2027 (the<B> </B>&#147;<B>2027</B><B> </B><B>Notes</B>&#148;) and $1,250,000,000 aggregate
principal amount of its 1.875% Senior Notes due 2031 (the<B> </B>&#147;<B>2031 Notes</B>&#148; and, together with the 2027 Notes, the &#147;<B>Notes</B>&#148;) to the several underwriters named on <U>Schedule I</U> hereto (the
&#147;<B>Underwriters</B>&#148;), for which Barclays Capital Inc., Goldman Sachs&nbsp;&amp; Co. LLC and J.P. Morgan Securities LLC are acting as representatives (the &#147;<B>Representatives</B>&#148;). The Notes will (a)&nbsp;have terms and
provisions which are summarized in the Disclosure Package as of the Applicable Time and the Prospectus dated as of the date hereof (each as defined in Section&nbsp;1(a) hereof) and (b)&nbsp;be issued pursuant to an Indenture dated as of
August&nbsp;15, 2006 (the &#147;<B>Indenture</B>&#148;) between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee (the &#147;<B>Trustee</B>&#148;). This agreement
(this &#147;<B>Agreement</B>&#148;) is to confirm the agreement concerning the purchase of the Notes from the Company by the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2027 Notes represent a further issuance of the Company&#146;s 1.300% Senior Notes due 2027 issued in an aggregate principal amount of
$1,500,000,000 on August&nbsp;21, 2020 (the &#147;<B>Existing 2027 Notes</B>&#148;). Except as otherwise described in the Disclosure Package (as defined below), the 2027 Notes will have identical terms to the Existing 2027 Notes and will be treated
as a single class with the Existing 2027 Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <I>Representations, Warranties and Agreements of the Company</I>. The Company
represents and warrants to, and agrees with, each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) An &#147;automatic shelf registration statement&#148; (as defined
in Rule 405 under the Securities Act of 1933, as amended (the &#147;<B>Securities Act</B>&#148;)) on Form <FONT STYLE="white-space:nowrap">S-3</FONT> in respect of the Notes (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-238506)</FONT> (i) has
been prepared by the Company in conformity with the requirements of the Securities Act and the rules and regulations (the &#147;<B>Rules and Regulations</B>&#148;) of the Securities and Exchange Commission (the &#147;<B>Commission</B>&#148;)
thereunder, (ii)&nbsp;has been filed with the Commission under the Securities Act not earlier than the date that is three years prior to the Closing Date and (iii)&nbsp;upon its filing with the Commission, automatically became and is effective under
the Securities Act. Copies of such registration statement and any amendment thereto (excluding exhibits to such registration statement but including all documents incorporated by reference in each prospectus </P>
<P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">contained therein) have been delivered by the Company to the Representatives; and no other document with
respect to such registration statement or any such document incorporated by reference therein has heretofore been filed or transmitted for filing with the Commission. For purposes of this Agreement, the following terms have the specified meanings:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Applicable Time</B>&#148; means 4:00 p.m. (New York City time) on the date of this Agreement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Base Prospectus</B>&#148; means the base prospectus filed as part of the Registration Statement, in the form in which
it has most recently been amended on or prior to the date hereof, relating to the Notes; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>&#147;</B><B>Disclosure
Package</B>&#148; means, as of the Applicable Time, the most recent Preliminary Prospectus, together with each Issuer Free Writing Prospectus filed or used by the Company on or before the Applicable Time and identified on <U>Schedule II</U> hereto,
other than a road show that is an Issuer Free Writing Prospectus under Rule 433 of the Rules and Regulations; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Effective Date</B>&#148; means any date as of which any part of the Registration Statement or any post-effective
amendment thereto relating to the Notes became, or is deemed to have become, effective under the Securities Act in accordance with the Rules and Regulations (including pursuant to Rule 430B of the Rules and Regulations); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Final Term Sheet</B>&#148; means the term sheet prepared pursuant to Section&nbsp;4(a) of this Agreement and
substantially in the form attached in <U>Schedule III</U> hereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Issuer Free Writing Prospectus</B>&#148; means
each &#147;free writing prospectus&#148; (as defined in Rule 405 of the Rules and Regulations) prepared by or on behalf of the Company or used or referred to by the Company in connection with the offering of the Notes, including the Final Term Sheet
and any other Issuer Free Writing Prospectus identified on <U>Schedule II</U> hereto; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Preliminary
Prospectus</B>&#148; means any preliminary prospectus relating to the Notes, including the Base Prospectus and any preliminary prospectus supplement thereto, included in the Registration Statement or as filed with the Commission pursuant to Rule
424(b) of the Rules and Regulations and provided to the Representatives for use by the Underwriters; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Prospectus</B>&#148; means the final prospectus relating to the Notes, including the Base Prospectus and the final
prospectus supplement thereto relating to the Notes, as filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations and provided to the Representatives for use by the Underwriters; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Registration Statement</B>&#148; means, collectively, the various parts of the above-referenced registration
statement, each as amended as of the Effective Date for such part, including any Preliminary Prospectus and the Prospectus, all exhibits to such registration statement and all documents incorporated by reference therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any reference to &#147;<B>the most recent Preliminary Prospectus</B>&#148; will be deemed to refer to the latest Preliminary Prospectus
included in the Registration Statement or filed pursuant to Rule 424(b) of the Rules and Regulations prior to or on the date hereof (including, for purposes of this Agreement, any documents incorporated by reference therein prior to or on the date
of this Agreement). Any reference to any Preliminary Prospectus or the Prospectus will be deemed to refer to and include any documents incorporated by reference therein pursuant to Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the
Securities Act as of the date of such Preliminary Prospectus or the Prospectus, as the case may be. Any reference to any amendment or supplement to any Preliminary Prospectus or the Prospectus will be deemed to refer to and include any document
filed under the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), after the date of such Preliminary Prospectus or the Prospectus, as the case may be, and incorporated by reference in such Preliminary Prospectus or
the Prospectus, as the case may be; and any reference to any amendment to the Registration Statement will be deemed to include any annual report of the Company on Form 10-K filed with the Commission pursuant to Section&nbsp;13(a) or 15(d) of the
Exchange Act after the Effective Date that is incorporated by reference in the Registration Statement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Commission has not issued any order preventing or suspending the effectiveness of
the Registration Statement or preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus; and no proceeding for any such purpose or pursuant to Section&nbsp;8A of the Securities Act against
the Company or related to the offering has been instituted or, to the Company&#146;s knowledge, threatened by the Commission. The Commission has not issued any order directed to any document incorporated by reference in the most recent Preliminary
Prospectus or the Prospectus, and no proceeding has been instituted or, to the Company&#146;s knowledge, threatened by the Commission with respect to any document incorporated by reference in the most recent Preliminary Prospectus or the Prospectus.
The Commission has not notified the Company of any objection to the use of the form of the Registration Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company has
been, and continues to be, a &#147;well-known seasoned issuer&#148; (as defined in Rule 405 of the Rules and Regulations) and has not been, and continues not to be, an &#147;ineligible issuer&#148; (as defined in Rule 405 of the Rules and
Regulations), in each case at all times relevant under the Securities Act in connection with the offering of the Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The
Registration Statement conformed on the Effective Date and conforms, and any amendment to the Registration Statement filed after the date hereof will conform, in all material respects, to the requirements of the Securities Act and the Rules and
Regulations. The most recent Preliminary Prospectus conforms on the date hereof, and the Prospectus, and any amendment or supplement thereto, will conform as of its date and as of the Closing Date, in all material respects, to the requirements of
the Securities Act and the Rules and Regulations. The documents of the Company incorporated by reference in the most recent Preliminary Prospectus or the Prospectus conformed, and any further documents so incorporated will conform, when filed with
the Commission, in all material respects to the requirements of the Exchange Act or the Securities Act, as applicable, and the Rules and Regulations; and no such documents have been filed with the Commission since the close of business of the
Commission on the Business Day immediately prior to the date hereof (other than those documents disclosed to the Representatives prior to the time of filing). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Registration Statement does not, as of the date hereof, contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein not misleading; <I>provided, however,</I> that no representation or warranty is made as to information contained in or omitted from the Registration Statement in reliance
upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein (which information is specified in Section&nbsp;12 hereof). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Disclosure Package did not, as of the Applicable Time, contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading; <I>provided, however,</I> that no representation or warranty is made as to information
contained in or omitted from the Disclosure Package in reliance upon and in conformity with written information furnished to the Company through the Representatives by or on behalf of any Underwriter specifically for inclusion therein (which
information is specified in Section&nbsp;12 hereof). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Prospectus, and any amendment or supplement thereto, will not, as of its date
and on the Closing Date, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading; <I>provided, however,</I> that no representation or warranty is made as to information contained in or omitted from the Prospectus in reliance upon and in conformity with written information furnished to the Company through the
Representatives by or on behalf of any Underwriter specifically for inclusion therein (which information is specified in Section&nbsp;12 hereof). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The documents of the Company incorporated by reference in the most recent Preliminary Prospectus or the Prospectus did not, and any further
documents incorporated by reference therein will not, when filed with the Commission, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company has been duly incorporated and is an existing corporation in good standing
under the laws of the State of Delaware, with corporate power and authority to own its properties and conduct its business as described in the most recent Preliminary Prospectus and the Prospectus; and the Company is duly qualified to do business as
a foreign corporation in good standing in all other jurisdictions in which its ownership or lease of property or the conduct of its business requires such qualification, except where the failure to be so qualified or be in good standing would not,
individually or in the aggregate, have a material adverse effect on the financial condition, business, properties, results of operations or affairs of the Company and its subsidiaries taken as a whole (a &#147;<B>Material Adverse Effect</B>&#148;).
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) Each subsidiary of the Company that is material to the Company and its subsidiaries taken as a whole (collectively, the
&#147;<B>Significant Subsidiaries</B>&#148;) is listed on <U>Exhibit A</U> hereto, together with its jurisdiction of organization and the beneficial ownership of the Company therein. Each Significant Subsidiary has been duly organized and is an
existing corporation or limited liability company in good standing under the laws of the jurisdiction of its organization, with corporate or limited liability company power and authority, as the case may be, to own its properties and conduct its
business as described in the most recent Preliminary Prospectus and the Prospectus; and each Significant Subsidiary of the Company is duly qualified to do business as a foreign entity in good standing in all other jurisdictions in which its
ownership or lease of property or the conduct of its business requires such qualification, except where the failure to be so qualified or be in good standing would not have a Material Adverse Effect; all of the issued and outstanding capital stock
or membership interests of each Significant Subsidiary of the Company have been duly authorized and validly issued and are fully paid and nonassessable; and the capital stock or membership interests of each Significant Subsidiary owned by the
Company, directly or through subsidiaries, are owned, except to the extent set forth in <U>Exhibit A</U> hereto, free and clear of any mortgage, pledge, lien, security interest, claim, encumbrance or defect of any kind. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) This Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) The Indenture has been duly authorized and executed by the Company and, assuming due authorization, execution and delivery by the Trustee,
constitutes a valid and legally binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other
similar laws relating to creditors&#146; rights and remedies generally and by general principles of equity and concepts of reasonableness (regardless of whether enforcement is sought in a proceeding at law or in equity); and the Indenture conforms
in all material respects to the description thereof contained in the most recent Preliminary Prospectus and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) The Notes
have been duly authorized by the Company, and when executed, authenticated and delivered and paid for as provided in this Agreement and the Indenture, the Notes will have been duly executed, authenticated, issued and delivered and will constitute
valid and legally binding obligations of the Company entitled to the benefits of the Indenture and enforceable against the Company in accordance with their terms, except to the extent that enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws relating to creditors&#146; rights and remedies generally and by general principles of equity and concepts of reasonableness (regardless of whether enforcement is sought in a proceeding at law or in
equity); and the Notes conform in all material respects to the description thereof contained in the Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) The execution, delivery and performance of the Indenture and this Agreement and the issuance and sale of the Notes will not require the
consent, approval, authorization or order of, or filing with, any governmental agency or body or any court (except such as have been obtained or made and such as may be required under state securities laws). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) The execution, delivery and performance of the Indenture and this Agreement and the issuance and sale of the Notes and compliance with the
terms and provisions thereof will not conflict with or result in a breach or violation of any of the terms and provisions of, and do not and will not constitute a default (or an event that, but for the giving of notice or the lapse of time or both,
would constitute an event of default) under, or result in the creation or imposition of any lien, charge or encumbrance upon any material assets or properties of the Company or any of its subsidiaries under (i)&nbsp;the charter, <FONT
STYLE="white-space:nowrap">by-laws</FONT> or other organizational documents of the Company or any Significant Subsidiary, (ii)&nbsp;any statute, rule, regulation, order or decree of any governmental or regulatory agency or body or any court,
domestic or foreign, having jurisdiction over the Company or any subsidiary or any of their properties, assets or operations or (iii)&nbsp;any indenture, mortgage, loan or credit agreement, note, lease, permit, license or other agreement or
instrument to which the Company or any subsidiary is a party or by which the Company or any subsidiary is bound or to which any of the properties, assets or operations of the Company or any subsidiary is subject, except, in the case of clauses
(ii)&nbsp;and (iii), for such breaches or violations which would not, individually or in the aggregate, have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) The Company and its subsidiaries have good and marketable title to all real properties
owned by them, in each case free and clear of any mortgage, pledge, lien, security interest, claim or other encumbrance or defect; the Company and its subsidiaries hold any leased real property under valid, subsisting and enforceable leases or
subleases with no exceptions that would materially interfere with the use made or to be made thereof by them; neither the Company nor any of its subsidiaries is in material default under any such lease or sublease; and no material claim of any sort
has been asserted by anyone adverse to the rights of the Company or any subsidiary under any such lease or sublease or affecting or questioning the right of such entity to the continued possession of the leased or subleased properties under any such
lease or sublease, except in each case as would not, individually or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) Except as
described in the most recent Preliminary Prospectus and the Prospectus, the Company and its subsidiaries possess adequate certificates, authorizations, licenses or permits issued by appropriate governmental agencies or bodies necessary to conduct
the business now operated by them, except as would not, individually or in the aggregate, have a Material Adverse Effect, and have not received any notice of proceedings relating to the revocation or modification of any such certificate,
authorization, license or permit that, individually or in the aggregate, could have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) The Company and each of
its subsidiaries have filed all tax returns required to be filed, which returns are complete and correct in all material respects, and neither the Company nor any of its subsidiaries is in default in the payment of any taxes which were payable
pursuant to said returns or any assessments with respect thereto, in each case except as would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s) Neither the filing of the Registration Statement, the most recent Preliminary Prospectus or the Prospectus nor the offer or sale of the
Notes as contemplated by this Agreement gives rise to any rights, other than those which have been duly waived or satisfied, for or relating to the registration of any securities of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) Except as described in the most recent Preliminary Prospectus and the Prospectus, (i)&nbsp;neither the Company nor any of its Significant
Subsidiaries is in violation of its charter or <FONT STYLE="white-space:nowrap">by-laws</FONT> or other organizational documents, (ii)&nbsp;neither the Company nor any of its subsidiaries is in violation of any applicable law, ordinance,
administrative or governmental rule or regulation, or any order, decree or judgment of any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries and (iii)&nbsp;no event of default or event that, but for
the giving of notice or the lapse of time or both, would constitute an event of default, exists, or as a result of the consummation of the sale of the Notes will exist, under any indenture, mortgage, loan agreement, note, lease, permit, license or
other agreement or instrument to which the Company or any of its subsidiaries is a party or to which any of the properties, assets or operations of the Company or any such subsidiary is subject, except, in the case of clauses (ii)&nbsp;and (iii),
for such violations and defaults that would not, individually or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) Except as described
in the most recent Preliminary Prospectus and the Prospectus, there are no pending actions, suits or proceedings against or, to the knowledge of the Company, affecting the Company, any of its subsidiaries or any of their respective properties,
assets or operations that would have, individually or in the aggregate, a Material Adverse Effect, or could materially and adversely affect the ability of the Company to perform its obligations under this Agreement, the Indenture or any other
document governing the sale of the Notes; and no such actions, suits or proceedings are, to the knowledge of the Company, threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v)
The financial statements of the Company and its consolidated subsidiaries, together with the related schedules, if any, and notes included or incorporated by reference in the most recent Preliminary Prospectus and the Prospectus, present fairly, in
all material respects, the respective financial position of the Company and its consolidated subsidiaries as of the dates shown and their results of operations and cash flows for the periods shown, and have been prepared in conformity with generally
accepted accounting principles in the United States applied on a consistent basis, except as disclosed therein. The other financial and statistical information set forth in the most recent Preliminary Prospectus and the Prospectus present fairly, in
all material respects, the information shown therein and have been, except as disclosed therein, compiled on a basis consistent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
with that of the financial statements included or incorporated by reference in the most recent Preliminary Prospectus and the Prospectus. The interactive data in eXtensible Business Reporting
Language incorporated by reference in the most recent Preliminary Prospectus and the Prospectus has been prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto (as of the dates such interactive data were filed) in
all material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(w) Since the date of the latest audited financial statements of the Company included or incorporated by reference
in the most recent Preliminary Prospectus and the Prospectus, there has been no material adverse change, nor any development or event involving a prospective material adverse change, in the financial condition, business, properties or results of
operations of the Company and its subsidiaries taken as a whole, other than those set forth in or contemplated by the most recent Preliminary Prospectus and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) There is no contract or document required to be described in the Registration Statement, the most recent Preliminary Prospectus or the
Prospectus or to be filed as an exhibit to the Registration Statement or to a document incorporated by reference into the Registration Statement, the most recent Preliminary Prospectus or the Prospectus which is not described or filed as required.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(y) The Company is not and, after giving effect to the offering and sale of the Notes and the application of the proceeds thereof as
described in the most recent Preliminary Prospectus and the Prospectus, will not be required to register as, an &#147;investment company&#148; as defined in the Investment Company Act of 1940, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(z) The Company and its Significant Subsidiaries maintain a system of internal accounting controls over financial reporting. The Company&#146;s
internal control over financial reporting include those policies and procedures that pertain to the Company&#146;s ability to record, process, summarize and report a system of internal accounting controls and procedures to provide reasonable
assurance, at an appropriate cost/benefit relationship, that the unauthorized acquisition, use or disposition of assets are prevented or timely detected and that transactions are authorized, recorded and reported properly to permit the preparation
of financial statements in accordance with generally accepted accounting principles in the United States and receipts and expenditures are duly authorized. The Company&#146;s internal control over financial reporting were effective and provided such
reasonable assurance for the preparation of financial statements as of December&nbsp;31, 2019, and there has been no change in the Company&#146;s internal control over financial reporting subsequent to December&nbsp;31, 2019 that has materially
affected, or is reasonably likely to materially affect, the Company&#146;s internal control over financial reporting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(aa) The Company has
made the evaluations of the Company&#146;s disclosure controls and procedures required under Rule <FONT STYLE="white-space:nowrap">13a-15(b)</FONT> under the Exchange Act and management&#146;s conclusions regarding the effectiveness of such
disclosure controls and procedures were included in the Company&#146;s annual report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2019. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(bb) Neither the Company nor any of its subsidiaries nor, to the Company&#146;s knowledge, any director, officer, agent, employee or affiliate
of the Company or any of its subsidiaries is aware of or has taken any action (with respect to any agent or affiliate, while acting on behalf of the Company or any of its subsidiaries), directly or indirectly, that would result in a violation by
such persons of the FCPA, including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or
other property, gift, promise to give, or authorization of the giving of anything of value to any &#147;foreign official&#148; (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign
political office, in contravention of the FCPA, and the Company, its subsidiaries and, to the Company&#146;s knowledge, its affiliates, have conducted their businesses in compliance in all material respects with the FCPA and have instituted and
maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">&#147;<B>FCPA</B>&#148; means Foreign Corrupt Practices Act of 1977, as amended, and the rules&nbsp;and regulations thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(cc) The operations of the Company and its subsidiaries are and have been conducted at all
times in compliance in all material respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable
jurisdictions, the rules&nbsp;and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &#147;<B>Money Laundering Laws</B>&#148;) and no
action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the Company&#146;s knowledge,
threatened. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(dd) Neither the Company nor any of its subsidiaries nor, to the Company&#146;s knowledge, any director, officer, agent,
employee or affiliate of the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#147;<B>OFAC</B>&#148;); and the Company will not
directly or indirectly use the net proceeds from the sale of the Notes, or lend, contribute or otherwise make available such proceeds, to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of
any person currently subject to any U.S. sanctions administered by OFAC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;1, as well as for
Section&nbsp;6 hereof, references to &#147;<B>the most recent Preliminary Prospectus and the Prospectus</B>&#148; or &#147;<B>the Disclosure Package and the Prospectus</B>&#148; are to each of the most recent Preliminary Prospectus or the Disclosure
Package, as the case may be, and the Prospectus as separate or stand-alone documentation (and not the most recent Preliminary Prospectus or the Disclosure Package, as the case may be, and the Prospectus taken together), so that representations,
warranties, agreements, conditions and legal opinions will be made, given or measured independently in respect of each of the most recent Preliminary Prospectus or the Disclosure Package, as the case may be, and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <I>Purchase of the Notes by the Underwriters</I>. Subject to the terms and conditions and upon the basis of the representations and
warranties herein set forth, the Company agrees to issue and sell to the Underwriters, and each of the Underwriters agrees, severally and not jointly, to purchase from the Company, at a price equal to (x)&nbsp;in the case of the 2027 Notes, 99.383%
of the principal amount of the 2027 Notes, plus accrued interest, from August&nbsp;21, 2020 to, but excluding, the Closing Date and (y)&nbsp;in the case of the 2031 Notes, 99.538% of the principal amount of the 2031 Notes, plus accrued interest, if
any, from December&nbsp;16, 2020 to, but excluding, the Closing Date, the respective principal amount of the Notes set forth opposite such Underwriter&#146;s name in <U>Schedule I</U> hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. <I>Delivery of and Payment for the Notes</I>. Delivery of the Notes will be made at the offices of Simpson Thacher&nbsp;&amp; Bartlett LLP,
425 Lexington Avenue, New York, NY 10017, or at such place or places as mutually may be agreed upon by the Company and the Underwriters, at 9:00 A.M., New York City time, on December&nbsp;16, 2020 or on such later date not more than seven Business
Days after such date as may be determined by the Representatives and the Company (the &#147;<B>Closing Date</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Delivery of the
Notes will be made to the Representatives by or on behalf of the Company against payment of the purchase price therefor by wire transfer of immediately available funds. Delivery of the Notes will be made through the facilities of The Depository
Trust Company unless the Representatives will otherwise instruct. Delivery of the Notes at the time and place specified in this Agreement is a further condition to the obligations of each Underwriter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. <I>Covenants of the Company</I>. The Company covenants and agrees with each Underwriter that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company (i)&nbsp;will prepare the Prospectus in a form approved by the Representatives and file the Prospectus pursuant to Rule 424(b)
of the Rules and Regulations within the time period prescribed by such Rule; (ii)&nbsp;will not file any amendment or supplement to the Registration Statement or the Prospectus or file any document under the Exchange Act (except for filings of
annual reports on Form 10-K and quarterly reports on Form 10-Q under the Exchange Act) before the termination of the offering of the Notes by the Underwriters if such document would be deemed to be incorporated by reference into the Prospectus,
which filing is not consented to by the Representatives after reasonable notice thereof (such consent not to be unreasonably withheld or delayed); (iii) will advise the Representatives, promptly after it receives notice thereof, of the time when any
amendment or supplement to the Registration Statement, the most recent Preliminary Prospectus or the Prospectus has been filed and will furnish the Representatives with copies thereof; (iv)&nbsp;will prepare the Final Term Sheet, substantially in
the form of <U>Schedule III</U> hereto and approved by the Representatives and file the Final Term Sheet </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
pursuant to Rule 433(d) of the Rules and Regulations within the time period prescribed by such Rule; (v)&nbsp;will advise the Representatives promptly after it receives notice thereof, of the
issuance by the Commission or any state or other regulatory body of any stop order or any order suspending the effectiveness of the Registration Statement, suspending or preventing the use of any Preliminary Prospectus, the Prospectus or any Issuer
Free Writing Prospectus or suspending the qualification of the Notes for offering or sale in any jurisdiction, of the initiation or threatening of any proceedings for any such purpose or pursuant to Section&nbsp;8A of the Securities Act, of receipt
by the Company from the Commission of any notice of objection to the use of the Registration Statement or any post-effective amendment thereto or of any request by the Commission for the amending or supplementing of the Registration Statement, the
Prospectus or any Issuer Free Writing Prospectus or for additional information; and (vi)&nbsp;will use its reasonable best efforts to prevent the issuance of any stop order or other such order or any such notice of objection and, if a stop order or
other such order is issued or any such notice of objection is received, to obtain as soon as possible the lifting or withdrawal thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company will furnish to each of the Underwriters and to counsel for the Underwriters such number of conformed copies of the
Registration Statement, as originally filed and each amendment thereto (excluding exhibits other than this Agreement), any Preliminary Prospectus, the Final Term Sheet and any other Issuer Free Writing Prospectus, the Prospectus and all amendments
and supplements to any of such documents (including any document filed under the Exchange Act and deemed to be incorporated by reference in the Registration Statement, any Preliminary Prospectus or the Prospectus), in each case as soon as available
and in such quantities as the Representatives may from time to time reasonably request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) During the period in which the Prospectus
relating to the Notes (or in lieu thereof, the notice referred to in Rule 173(a) of the Rules and Regulations) is required to be delivered under the Securities Act, the Company will comply with all requirements imposed upon it by the Securities Act
and by the Rules and Regulations, as from time to time in force, so far as is necessary to permit the continuance of sales of or dealings in the Notes as contemplated by the provisions of this Agreement and by the Prospectus. If during such period
any event occurs as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, or if during such period it is necessary to amend the Registration Statement or amend or supplement the Prospectus or file any document to comply with the Securities Act, the Company will promptly notify
the Representatives and will, subject to Section&nbsp;4(a) hereof, amend the Registration Statement, or amend or supplement the Prospectus, as the case may be, or file any document (in each case, at the expense of the Company) so as to correct such
statement or omission or to effect such compliance, and will furnish without charge to each Underwriter as many written and electronic copies of any such amendment or supplement as the Representatives may from time to time reasonably request.
Neither the Representatives&#146; consent to nor their delivery to offerees or investors of, any such amendment or supplement shall constitute a waiver of any of the conditions set forth in Section&nbsp;6 of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) As soon as practicable, the Company will make generally available to its security holders and the Underwriters an earnings statement
satisfying the requirements of Section&nbsp;11(a) of the Securities Act and Rule 158 of the Rules and Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company agrees,
whether or not this Agreement becomes effective or is terminated or the sale of the Notes to the Underwriters is consummated, to pay all fees, expenses, costs and charges in connection with: (i)&nbsp;the preparation, printing, filing, registration,
delivery and shipping of the Registration Statement (including any exhibits thereto), any Preliminary Prospectus, any Issuer Free Writing Prospectus, the Prospectus and any amendments or supplements thereto; (ii)&nbsp;the printing, producing,
copying and delivering of this Agreement, the Indenture, closing documents (including any compilations thereof) and any other agreements, memoranda, correspondence and other documents printed and delivered in connection with the offering, purchase,
sale and delivery of the Notes; (iii)&nbsp;the services of the Company&#146;s independent registered public accounting firm; (iv)&nbsp;the services of the Company&#146;s counsel; (v)&nbsp;the qualification of the Notes under the securities laws of
the several jurisdictions as provided in Section&nbsp;4(i) hereof; (vi)&nbsp;any rating of the Notes by rating agencies; (vii)&nbsp;the services of the Trustee and any agent of the Trustee (including the fees and disbursements of counsel for the
Trustee); (viii) any &#147;road show&#148; or other investor presentations relating to the offering of the Notes (including, without limitation, for meetings and travel); and (ix)&nbsp;the performance of its otherwise incident obligations hereunder
for which provision is not otherwise made in this Section&nbsp;4(e). It is understood, however, that, except as provided in this Section&nbsp;4(e) or Sections 7 and 9 hereof, the Underwriters will pay all of their own costs and expenses, including
the fees and expenses of counsel to the Underwriters and any advertising expenses incurred in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
connection with the offering of the Notes. If the sale of the Notes provided for herein is not consummated by reason of acts of the Company or changes in circumstances of the Company pursuant to
Section&nbsp;9 of this Agreement which prevent this Agreement from becoming effective, or by reason of any failure, refusal or inability on the part of the Company to perform any agreement on its part to be performed or because any other condition
of the Underwriters&#146; obligations hereunder is not fulfilled or if the Underwriters decline to purchase the Notes for any reason permitted under this Agreement (other than by reason of a default by any of the Underwriters pursuant to
Section&nbsp;8 or if the Underwriters terminate this Agreement under Section&nbsp;9 of this Agreement upon the occurrence of any event specified in clause (iii), (iv), (vi), (vii) or (viii)&nbsp;of Section&nbsp;6(d)), the Company will reimburse the
Underwriters for all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> disbursements (including fees and expenses of counsel to the Underwriters) incurred by the Underwriters in connection with
any investigation or preparation made by them in respect of the marketing of the Notes or in contemplation of the performance by them of their obligations hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Until termination of the offering of the Notes, the Company will timely file all reports, documents and amendments to previously filed
documents required to be filed by it pursuant to Section&nbsp;12, 13(a), 13(c), 14 or 15(d) of the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Company will
apply the net proceeds from the sale of the Notes as set forth in the most recent Preliminary Prospectus and the Prospectus under the caption &#147;Use of Proceeds.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Company will pay the required Commission filing fees relating to the Notes within the time period required by Rule 456(b)(1) of the
Rules and Regulations without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) of the Rules and Regulations. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The Company will use reasonable best efforts to arrange for the qualification of the Notes and the determination of their eligibility for
investment under the blue sky laws of such jurisdictions as the Representatives designate and will continue such qualifications in effect so long as required for the distribution of the Notes by the Underwriters, provided that the Company will not
be required to qualify as a foreign corporation or to file a general consent to service of process or subject itself to taxation in any such jurisdiction. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. <I>Free Writing Prospectuses</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company represents and warrants to, and agrees with, each Underwriter that (i)&nbsp;the Company has not made, and will not make, any
offer relating to the Notes that would constitute an Issuer Free Writing Prospectus without the prior consent of the Representatives (which consent being deemed to have been given with respect to (A)&nbsp;the Final Term Sheet prepared and filed
pursuant to Section&nbsp;4(a) hereof and (B)&nbsp;any other Issuer Free Writing Prospectus identified on <U>Schedule II</U> hereto); (ii) each Issuer Free Writing Prospectus conformed or will conform in all material respects to the requirements of
the Securities Act and the Rules and Regulations on the date of first use, and the Company has complied with any filing requirements applicable to such Issuer Free Writing Prospectus pursuant to Rule 433 of the Rules and Regulations; (iii)&nbsp;each
Issuer Free Writing Prospectus will not, as of its issue date and through the time the Notes are delivered pursuant to Section&nbsp;3 hereof, include any information that conflicts with the information contained in the Registration Statement, the
most recent Preliminary Prospectus and the Prospectus; and (iv)&nbsp;each Issuer Free Writing Prospectus, when considered together with the information contained in the most recent Preliminary Prospectus, did not, as of the Applicable Time, does
not, as of the date hereof, and will not, as of the Closing Date, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Underwriter represents and warrants to, and agrees with, the Company
and each other Underwriter that it has not made, and will not make any offer relating to the Notes that would constitute a &#147;free writing prospectus&#148; (as defined in Rule&nbsp;405 of the Rules and Regulations) required to be filed with the
Commission, without the prior consent of the Company and the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Company agrees that if at any time following
issuance of an Issuer Free Writing Prospectus any event occurred or occurs as a result of which such Issuer Free Writing Prospectus would conflict with the information in the Registration Statement, the most recent Preliminary Prospectus or the
Prospectus or would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances then prevailing, not misleading, the Company will give prompt
notice thereof to the Representatives and, if requested by the Representatives, will prepare and furnish without charge to each Underwriter an Issuer Free Writing Prospectus or other document which will correct such conflict, statement or omission.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6. <I>Conditions of Underwriters</I><I>&#146;</I><I> Obligations</I>. The obligations of the
Underwriters hereunder are subject to the accuracy, as of the date hereof and the Closing Date (as if made at the Closing Date), of the representations and warranties of the Company contained herein, to the performance by the Company of its
obligations hereunder and to the following additional conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Prospectus shall have been filed with the Commission in a timely
fashion in accordance with Section&nbsp;4(a) hereof; all filings (including, without limitation, the Final Term Sheet) required by Rule 424(b) or Rule 433 of the Rules and Regulations shall have been made within the time periods prescribed by such
Rules, and no such filings will have been made without the consent of the Representatives (such consent not to be unreasonably withheld or delayed); no stop order suspending the effectiveness of the Registration Statement or any amendment or
supplement thereto, preventing or suspending the use of any Preliminary Prospectus, any Issuer Free Writing Prospectus or the Prospectus, or suspending the qualification of the Notes for offering or sale in any jurisdiction shall have been issued;
no proceedings for the issuance of any such order shall have been initiated or threatened pursuant to Section&nbsp;8A of the Securities Act; no notice of objection of the Commission to use of the Registration Statement or any post-effective
amendment thereto shall have been received by the Company; and any request of the Commission for additional information (to be included in the Registration Statement or the Prospectus or otherwise) shall have been disclosed to the Representatives
and complied with to the Representatives&#146; reasonable satisfaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Representatives shall have received a letter, dated the
date of this Agreement, from Ernst&nbsp;&amp; Young LLP (&#147;<B>E&amp;Y</B>&#148;) addressed to the Underwriters, confirming that they are the independent public accountants with respect to the Company, within the meaning of the Securities Act and
the applicable published rules and regulations thereunder and to the effect that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) in their opinion the financial
statements and schedules of the Company, if any, examined by them and included or incorporated by reference in the most recent Preliminary Prospectus or the Prospectus, comply as to form in all material respects with the applicable accounting
requirements of the Securities Act and the Exchange Act and the related rules and regulations adopted by the Commission; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) on the basis of a reading of the latest available interim financial statements of the Company, inquiries of officials of
the Company, who have responsibility for financial and accounting matters and other specified procedures, nothing came to their attention that caused them to believe that: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at the date of the latest available balance sheet read by such accountants, and at a subsequent specified date
not more than three Business Days prior to the date of this Agreement, there was any change in the common stock, increase in long-term debt or decrease in consolidated net current assets or shareholders&#146; equity of the Company, as compared with
amounts shown on the latest balance sheet included or incorporated by reference in the most recent Preliminary Prospectus or the Prospectus; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">for the period from the closing date of the latest income statement included or incorporated by reference in
the most recent Preliminary Prospectus or the Prospectus to the closing date of the latest available income statement read by such accountants and to a subsequent specified date not more than three Business Days prior to the date of this Agreement,
there were any decreases, as compared with the corresponding period in the preceding year, in consolidated net revenues or in the total or <FONT STYLE="white-space:nowrap">per-share</FONT> amounts of consolidated income from continuing operations or
of consolidated net income of the Company, or any increases or decreases, as the case may be, in other items specified by the Representatives; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">except in all cases set forth in clauses (A)&nbsp;and (B) above for changes, increases or decreases which the
most recent Preliminary Prospectus or the Prospectus discloses have occurred or may occur or which are described in such letter; and </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) they have compared specified dollar amounts (or percentages derived from such dollar amounts), numerical data and other
financial information contained in the most recent Preliminary Prospectus or the Prospectus (in each case to the extent that such dollar amounts, percentages, numerical data and other financial information are derived from the general accounting
records of the Company and its subsidiaries, subject to the internal controls of the Company&#146;s accounting system, or are derived directly from such records by analysis or computation) with the results obtained from inquiries, a reading of such
general accounting records and other procedures specified in such letter and have found such dollar amounts, percentages, numerical data and other financial information to be in agreement with such results except as otherwise specified in such
letter. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Representatives shall have received a letter, addressed to the Underwriters, dated the Closing Date, from E&amp;Y, which
meets the requirements of subsection (b)&nbsp;of this Section, except that the specified date referred to in such subsection will be a date not more than three days prior to the Closing Date for the purposes of this subsection. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Subsequent to the execution and delivery of this Agreement, there shall not have occurred (i)&nbsp;any change, or any development involving
a prospective change, in the condition (financial or other), business, properties or results of operations of the Company and its subsidiaries, taken as a whole, which, in the judgment of the Representatives, is material and adverse and makes it
impractical or inadvisable to proceed with completion of the offering or the sale of and payment for the Notes; (ii)&nbsp;any downgrading in the rating of any debt securities of the Company by any &#147;nationally recognized statistical rating
organization&#148; (as defined for purposes of Section&nbsp;3(a)(62) of the Exchange Act), or any public announcement that any such organization has under surveillance or review its rating of any debt securities of the Company (other than an
announcement with positive implications of a possible upgrading, and no implication of a possible downgrading, of such rating); (iii)&nbsp;any change in U.S. or international financial, political or economic conditions or currency exchange rates or
exchange controls as would, in the judgment of the Representatives, be likely to prejudice materially the success of the proposed issue, sale or distribution of the Notes, whether in the primary market or in respect of dealings in the secondary
market; (iv)&nbsp;any material suspension or material limitation of trading in securities generally on the New York Stock Exchange or any setting of minimum prices for trading on such exchange; (v)&nbsp;any suspension of trading of any securities of
the Company on any exchange or in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (vi)&nbsp;any banking moratorium declared by U.S. Federal or New York authorities; (vii)&nbsp;any major
disruption of settlements of securities or clearance services in the United States; or (viii)&nbsp;any attack on the United States, outbreak or escalation of major hostilities or act of terrorism involving the United States, any declaration of war
by Congress or any other substantial national or international calamity or emergency if, in the judgment of the Representatives, the effect of any such attack, outbreak, escalation, act, declaration, calamity or emergency makes it impractical or
inadvisable to proceed with completion of the offering or sale of and payment for the Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Representatives shall have received
from Shearman&nbsp;&amp; Sterling LLP, counsel for the Company, an opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> letter, addressed to the Underwriters, dated the Closing Date substantially to the effect set forth in <U>Exhibits B</U> and
<U>C</U> hereto, respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) The Representatives shall have received from Thomas S. Moffatt, Vice President, Assistant Corporate
Secretary and Assistant General Counsel of the Company, an opinion, addressed to the Underwriters, dated the Closing Date substantially in the form of <U>Exhibit D</U> hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) The Representatives shall have received from Simpson Thacher&nbsp;&amp; Bartlett LLP, counsel to the Underwriters, such opinion or
opinions, addressed to the Underwriters, dated the Closing Date and in form and substance satisfactory to the Representatives, with respect to the Notes, Indenture, Registration Statement, Prospectus and Disclosure Package and other related matters
as the Representatives may reasonably require, and the Company shall have furnished to such counsel such documents as they may reasonably request for the purpose of enabling them to pass upon such matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) The Representatives shall have received a certificate, dated the Closing Date, of the
President or any Vice President and the principal financial or accounting officer of the Company in which such officers, to the best of their knowledge after reasonable investigation, shall state that (i)&nbsp;the representations and warranties of
the Company in this Agreement are true and correct, (ii)&nbsp;the Company has complied with all the agreements and satisfied all the conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date, (iii)&nbsp;no stop
order suspending the effectiveness of the Registration Statement has been issued, no proceedings for any such purpose have been initiated or threatened and (iv)&nbsp;subsequent to the dates of the most recent financial statements in the most recent
Preliminary Prospectus and the Prospectus, there has been no material adverse change, nor any development or event involving a prospective material adverse change, in the financial condition, business, properties or results of operations of the
Company and its subsidiaries, taken as a whole, other than those set forth in or contemplated by the most recent Preliminary Prospectus and the Prospectus or as described in such certificate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company will furnish the Underwriters with such conformed copies of such opinions, certificates, letters and documents as the Underwriters
reasonably request. The Representatives may in their sole discretion waive on behalf of the Underwriters compliance with any conditions to the obligations of the Underwriters hereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. <I>Indemnification and Contribution</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company will indemnify and hold harmless each Underwriter, its partners, members, directors and officers and affiliates and each
person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act, from and against any loss, claim, damage or liability (or any action in respect thereof), joint or several, to which such Underwriter or such
person may become subject, under the Securities Act or otherwise, insofar as such loss, claim, damage or liability (or action in respect thereof) arises out of or is based upon (i)&nbsp;any untrue statement or alleged untrue statement of a material
fact contained in the Registration Statement, any Preliminary Prospectus, the Prospectus, or the Disclosure Package, each as amended or supplemented, any Issuer Free Writing Prospectus or any &#147;issuer information&#148; filed or required to be
filed pursuant to Rule&nbsp;433(d) of the Rules and Regulations or (ii)&nbsp;the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of any Preliminary
Prospectus, Issuer Free Writing Prospectus, the Prospectus and the Disclosure Package, in the light of the circumstances under which they were made) not misleading, and will reimburse each Underwriter for any legal or other expenses as reasonably
incurred by such Underwriter in connection with investigating, preparing to defend or defending against or appearing as a third-party witness in connection with any such loss, claim, damage, liability or action, notwithstanding the possibility that
payments for such expenses might later be held to be improper, in which case such payments will be promptly refunded; <I>provided</I>, <I>however</I>, that the Company will not be liable under this Section&nbsp;7(a) in any such case to the extent
that any such loss, claim, damage, liability or action arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with written information furnished to the
Company by any Underwriter through the Representatives specifically for use therein (which information is specified in Section&nbsp;12 hereof). The foregoing indemnity agreement shall not inure to the benefit of any Underwriter if (i)&nbsp;such
loss, claim, damage or liability (or action in respect thereof) arises out of or is based upon an untrue statement or alleged untrue statement or omission or alleged omission made in any Preliminary Prospectus, (ii)&nbsp;the Company informed the
Representatives of such untrue statement or alleged untrue statement or omission or alleged omission prior to the Applicable Time, (iii)&nbsp;such untrue statement or alleged untrue statement or omission or alleged omission was corrected in an
amended or supplemented Preliminary Prospectus (or, where permitted by law, an Issuer Free Writing Prospectus) and such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) was provided to the Underwriters such that the Underwriters
had a reasonably sufficient amount of time prior to the Applicable Time to deliver such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) to the persons to whom the Underwriters are selling the Notes, (iv)&nbsp;the timely delivery
of such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) to such person prior to the Applicable Time would have constituted a complete defense to the losses, claims, damages and liabilities asserted by such person and
(v)&nbsp;such corrected Preliminary Prospectus (or Issuer Free Writing Prospectus) was not sent or given by or on behalf of such Underwriter to such person prior to the Applicable Time. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Each Underwriter severally, but not jointly, will indemnify and hold harmless the Company, its directors, officers and affiliates and each
person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities Act against any loss, claim, damage or liability (or any action in respect thereof) to which the Company or such person may become subject, under the
Securities Act or otherwise, insofar as such loss, claim, damage or liability (or action in respect thereof) arises out of or is based upon (i)&nbsp;any untrue </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statement or alleged untrue statement of a material fact contained in the Registration Statement, any Preliminary Prospectus, the Prospectus, the Disclosure Package, each as amended or
supplemented, or any Issuer Free Writing Prospectus or (ii)&nbsp;the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of any Preliminary Prospectus,
Issuer Free Writing Prospectus, the Prospectus and the Disclosure Package, in the light of the circumstances under which they were made) not misleading, and will reimburse the Company for any legal or other expenses reasonably incurred by the
Company in connection with investigating, preparing to defend or defending against or appearing as a third-party witness in connection with any such loss, claim, damage, liability or action notwithstanding the possibility that payments for such
expenses might later be held to be improper, in which case such payments will be promptly refunded; <I>provided</I>, <I>however</I>, that such indemnification or reimbursement will be available in each such case to the extent, but only to the
extent, that such untrue statement or alleged untrue statement or omission or alleged omission was made in reliance upon and in conformity with written information furnished to the Company by such Underwriter through the Representatives,
specifically for use therein (which information is specified in Section&nbsp;12 hereof). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Promptly after receipt by an indemnified
party under this Section of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under subsection (a)&nbsp;or (b) above, notify the indemnifying party of the
commencement thereof; but the failure to notify the indemnifying party shall not relieve it from any liability that it may have under subsection (a)&nbsp;or (b) above, except to the extent that it has been materially prejudiced (through the
forfeiture of substantive rights or defenses) by such failure; and provided further that the failure to notify the indemnifying party shall not relieve it from any liability that it may have to an indemnified party otherwise than under subsection
(a)&nbsp;or (b) above. In case any such action is brought against any indemnified party and it notifies an indemnifying party of the commencement thereof, the indemnifying party will be entitled to participate therein and, to the extent that it may
wish, jointly with any other indemnifying party similarly notified, to assume the defense thereof, with counsel satisfactory to such indemnified party (who shall not, except with the consent of the indemnified party, be counsel to the indemnifying
party), and after notice from the indemnifying party to such indemnified party of its election to assume the defense thereof, the indemnifying party will not be liable to such indemnified party under this Section for any legal or other expenses
subsequently incurred by such indemnified party in connection with the defense thereof other than reasonable costs of investigation. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of
any pending or threatened action in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party unless such settlement (i)&nbsp;includes an unconditional release of
such indemnified party from all liability on any claims that are the subject matter of such action and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf of any indemnified party.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) If the indemnification provided for in this Section is unavailable or insufficient to hold harmless an indemnified party under
subsection (a)&nbsp;or (b) above, then the indemnifying party shall contribute to the amount paid or payable by such indemnified party as a result of the losses, claims, damages or liabilities referred to in subsection (a)&nbsp;or (b) above
(i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Notes or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;above
is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;above but also the relative fault of the Company on the one hand and the Underwriters on the other in
connection with the statements or omissions which resulted in such losses, claims, damages or liabilities as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters on
the other shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company bear to the total discounts and commissions received by the Underwriters from the Company under
this Agreement. The relative fault shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Company or the Underwriters and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The amount paid by an indemnified party as a result of the
losses, claims, damages or liabilities referred to in the first sentence of this subsection (d)&nbsp;shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending
any action or claim which is the subject of this subsection (d). Notwithstanding the provisions of this subsection (d), no Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Notes
purchased by it were resold exceeds the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. The Underwriters&#146;
obligations in this subsection (d)&nbsp;to contribute are several in proportion to their respective purchase obligations and not joint. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The obligations of the
Company under this Section shall be in addition to any liability which the Company may otherwise have and shall extend, upon the same terms and conditions, to each person, if any, who controls any Underwriter within the meaning of the Securities Act
or the Exchange Act; and the obligations of the Underwriters under this Section shall be in addition to any liability which the Underwriters may otherwise have and shall extend, upon the same terms and conditions, to each director of the Company and
to each person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8. <I>Substitution of
Underwriters</I>. If any Underwriter or Underwriters default in their obligations to purchase Notes hereunder and the aggregate principal amount of the Notes that such defaulting Underwriter or Underwriters agreed but failed to purchase does not
exceed 10% of the total principal amount of the Notes, the Representatives may make arrangements satisfactory to the Company for the purchase of such Notes by other persons, including any of the Underwriters, but if no such arrangements are made by
the Closing Date, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters shall be obligated severally, in proportion to their respective commitments hereunder, to purchase the Notes that such defaulting Underwriter or Underwriters
agreed but failed to purchase. If any Underwriter or Underwriters so default and the aggregate principal amount of the Notes with respect to which such default or defaults occur exceeds 10% of the total principal amount of the Notes and arrangements
satisfactory to the Representatives and the Company for the purchase of such Notes by other persons are not made within 36 hours after such default, this Agreement will terminate without liability on the part of any
<FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter or the Company, except as provided in Section&nbsp;7. As used in this Agreement, the term &#147;Underwriter&#148; includes any person substituted for an Underwriter under this
Section. Nothing herein will relieve a defaulting Underwriter from liability for its default. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9. <I>Termination</I>. Until the Closing
Date, this Agreement may be terminated by the Representatives on behalf of the Underwriters by giving notice as hereinafter provided to the Company if (i)&nbsp;the Company will have failed, refused or been unable, at or prior to the Closing Date, to
perform any agreement on its part to be performed hereunder, (ii)&nbsp;any of the events described in Sections 6(d) of this Agreement, shall have occurred, or (iii)&nbsp;any other condition to the Underwriters&#146; obligations hereunder is not
fulfilled. Any termination of this Agreement pursuant to this Section&nbsp;9 will be without liability on the part of the Company or any Underwriter, except as otherwise provided in Sections&nbsp;4(e) and 7 hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any notice referred to above may be given at the address specified in Section&nbsp;11 of this Agreement in writing or by telegraph or
telephone, and if by telegraph or telephone, will be immediately confirmed in writing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">10. <I>Survival of Certain Provisions</I>. The
agreements contained in Section&nbsp;7 of this Agreement and the representations, warranties and agreements of the Company contained in Sections&nbsp;1 and 4 of this Agreement will survive the delivery of the Notes to the Underwriters hereunder and
will remain in full force and effect, regardless of any termination or cancellation of this Agreement or any investigation made by or on behalf of any indemnified party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">11. <I>Notices</I>. Except as otherwise provided in the Agreement, (a)&nbsp;whenever notice is required by the provisions of this Agreement to
be given to the Company, such notice will be in writing by mail, telex or facsimile transmission addressed to the Company at One CVS Drive, Woonsocket, Rhode Island 02895, facsimile number (401) <FONT STYLE="white-space:nowrap">765-7887,</FONT>
Attention: General Counsel, and (b)&nbsp;whenever notice is required by the provisions of this Agreement to be given to the several Underwriters, such notice will be in writing by mail, telex or facsimile transmission addressed to the
Representatives in care of Barclays Capital Inc., 745 Seventh Ave, New York, New York 10019, facsimile number: (646) <FONT STYLE="white-space:nowrap">834-8133,</FONT> Attention: Syndicate Registration, Goldman Sachs&nbsp;&amp; Co. LLC, 200 West
Street, New York, New York 10282, Attention: Registration Department and J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, facsimile number: (212) <FONT STYLE="white-space:nowrap">834-6081,</FONT> Attention: Investment Grade
Syndicate Desk. The Company shall be entitled to act and rely upon any request, consent, notice or agreement given or made on behalf of the Underwriters by the Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">12. <I>Information Furnished by Underwriters</I>. The Underwriters severally confirm that
the names of each of the Underwriters under the caption &#147;Underwriting&#148; in the most recent Preliminary Prospectus and the Prospectus, the concession and reallowance figures appearing in the table below the third paragraph under the caption
&#147;Underwriting&#148; in the most recent Preliminary Prospectus and the Prospectus, and the statements in the first two paragraphs (including the bullet points between those paragraphs) of the subsection entitled &#147;Price Stabilization, Short
Positions and Penalty Bids&#148; under the caption &#147;Underwriting&#148; in the most recent Preliminary Prospectus and the Prospectus, constitute the only written information furnished to the Company by the Representatives on behalf of the
Underwriters, referred to in Sections&nbsp;1(e), 1(f), 1(g), 7(a) and 7(b) of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">13. <I>Nature of Relationship</I>. The
Company acknowledges and agrees that in connection with the offering and the sale of the Notes or any other services the Underwriters may be deemed to be providing hereunder, notwithstanding any preexisting relationship, advisory or otherwise,
between the parties or any oral representations or assurances previously or subsequently made by the Underwriters: (i)&nbsp;no fiduciary or agency relationship between the Company and any other person, on the one hand, and the Underwriters, on the
other hand, exists; (ii)&nbsp;the Underwriters are not acting as advisors, experts or otherwise, to the Company, including, without limitation, with respect to the determination of the public offering price of the Notes, and such relationship
between the Company, on the one hand, and the Underwriters, on the other hand, is entirely and solely a commercial relationship, based on arms-length negotiations; (iii)&nbsp;any duties and obligations that the Underwriters may have to the Company
shall be limited to those duties and obligations specifically stated herein; and (iv)&nbsp;the Underwriters and their respective affiliates may have interests that differ from those of the Company. The Company hereby waives any claims that the
Company may have against the Underwriters with respect to any breach of fiduciary duty in connection with this offering. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">14.
<I>Recognition of the U.S. Special Resolution Regime</I> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event that any Underwriter is a Covered Entity and becomes subject to
a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the
U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States.<I> </I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that any Underwriter is a Covered Entity and it or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding
under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special
Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As used in this
Section&nbsp;14: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>BHC Act Affiliate</B>&#148; has the meaning assigned to the term &#147;<B>affiliate</B>&#148;
in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Covered Entity</B>&#148; means any of
the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R.
&#167; 252.82(b); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12
C.F.R. &#167; 47.3(b); or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with,
12 C.F.R. &#167; 382.2(b).</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Default Right</B>&#148; has the meaning assigned to that term in, and shall be
interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>U.S. Special Resolution Regime</B>&#148; means each of (i)&nbsp;the
Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">15. <I>Parties</I>. This Agreement will inure to the benefit of and be binding upon the several Underwriters, the Company and their respective
successors. This Agreement and the terms and provisions hereof are for the sole benefit of only those persons, except as specifically provided in Section&nbsp;7 of this Agreement. Nothing in this Agreement will be construed to give any person, other
than the persons referred to in this paragraph, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">16. <I>Definition of </I><I>&#147;</I><I>Business Day</I><I>&#148;</I><I>.</I> For purposes of this Agreement, the term &#147;<B>Business
Day</B>&#148; means any day on which the New York Stock Exchange is open for trading, other than any day on which commercial banks are authorized or required to be closed in New York City. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">17. <I>Governing Law</I>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">18. <I>Headings</I>. The headings herein are inserted for convenience of reference only and are not intended to be part of, or to affect the
meaning or interpretation of, this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">19. <I>Counterparts</I>. This Agreement may be signed in one or more counterparts, each of
which will constitute an original and all of which together will constitute one and the same agreement. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000,
Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and
be valid and effective for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Remainder of page intentionally left blank; Signatures follow</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Please confirm, by signing and returning to us one or more counterparts of this Agreement,
that the foregoing correctly sets forth the Agreement between the Company and the several Underwriters. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CVS HEALTH CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carol A. DeNale</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Carol A. DeNale</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Senior Vice President and Treasurer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Confirmed and accepted as of the date first above mentioned</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BARCLAYS CAPITAL INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Barbara Mariniello</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Barbara Mariniello</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">GOLDMAN SACHS&nbsp;&amp; CO. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam T. Greene</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Adam T. Greene</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SECURITIES LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Som Bhattacharyya</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Som Bhattacharyya</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Executive Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representatives and on behalf of the several Underwriters named in <U>Schedule I</U> hereto </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount<BR>of&nbsp;the 2027 Notes<BR>to be purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal Amount<BR>of&nbsp;the 2031 Notes<BR>to be purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">90,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">150,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">90,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">150,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">90,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">150,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">73,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">122,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">73,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">122,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Credit Suisse Securities (USA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loop Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">MUFG Securities Americas Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Bancorp Investments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fifth Third Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Santander Investment Securities Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SMBC Nikko Securities America, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNY Mellon Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ICBC Standard Bank Plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KeyBanc Capital Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TD Securities (USA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">13,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">American Veterans Group, PBC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Great Pacific Securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Seelaus&nbsp;&amp; Co., LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">750,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,250,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ISSUER FREE WRITING PROSPECTUSES </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Final Term Sheet, dated December&nbsp;7, 2020, relating to the Notes, as filed pursuant to Rule 433 under the
Securities Act and attached as <U>Schedule III</U> hereto. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PRICING TERM SHEET </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Filed pursuant to Rule 433 </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Free Writing Prospectus dated December&nbsp;7, 2020 </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Registration Statement No.: <FONT STYLE="white-space:nowrap">333-238506</FONT> </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CVS HEALTH CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Pricing Term Sheet&#151;December 7, 2020 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>$750,000,000 1.300% Senior Notes due 2027 (constituting a further issuance of the 1.300% Senior Notes due 2027, of which $1,500,000,000
aggregate principal amount was issued on August&nbsp;21, 2020) </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>$1,250,000,000 1.875% Senior Notes due 2031 </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Issuer:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">CVS Health Corporation (the &#147;<B>Issuer</B>&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Description of Securities:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$750,000,000 1.300%<B><I> </I></B>Senior Notes due 2027 (&#147;<B>2027 Notes</B>&#148;)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">$1,250,000,000 1.875%<B><I> </I></B>Senior Notes due 2031 (&#147;<B>2031 Notes</B>&#148; and, together with the 2027 Notes, the &#147;<B>Notes</B>&#148;)</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The 2027 Notes constitute a further issuance of the Issuer&#146;s 1.300% Senior Notes
due 2027, of which $1,500,000,000 aggregate principal amount was issued on August&nbsp;21, 2020 (the &#147;<B>Initial 2027 Notes</B>&#148;). Upon settlement, the 2027 Notes will have the same CUSIP and will trade interchangeably with the Initial
2027 Notes. We expect the 2027 Notes to be fungible for U.S. federal income tax purposes with the Initial 2027 Notes. Immediately after giving effect to this offering, the total amount outstanding of our 1.300% Senior Notes due 2027 will be
$2,250,000,000.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Maturity Dates:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August&nbsp;21, 2027 for the 2027 Notes</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">February&nbsp;28, 2031 for the 2031 Notes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Settlement Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">December&nbsp;16, 2020 (T+7)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Extended Settlement:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">It is expected that delivery of the Notes will be made, against payment of the Notes, on or about December 16, 2020, which will be the seventh business day in the United States following the date of pricing of the Notes. Under Rule <FONT
STYLE="white-space:nowrap">15c6-1</FONT> under the Securities Exchange Act of 1934, as amended, purchases or sales of securities in the secondary market generally are required to settle within two business days (T+2), unless the parties to any such
transaction expressly agree otherwise. Accordingly, purchasers of the Notes who wish to trade the Notes prior to the second business day before delivery of the Notes will be required, because the Notes initially will settle within seven business
days (T+7) in the United States, to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement. Purchasers of the Notes who wish to trade the Notes prior to December&nbsp;16, 2020 should consult their
advisors.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Issue Prices:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">99.783% of principal amount for the 2027 Notes, plus interest deemed to have accrued from and including August&nbsp;21, 2020 to, but
excluding, December&nbsp;16, 2020</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">99.988% of principal amount for the 2031
Notes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Coupons:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.300% for the 2027 Notes</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">1.875% for the 2031
Notes</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Benchmark Treasury:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2027 Notes: 0.625% UST due November&nbsp;30, 2027</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2030 Notes: 0.875% UST due November&nbsp;15, 2030</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Benchmark&nbsp;Treasury&nbsp;Price&nbsp;and Yield:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2027 Notes: <FONT STYLE="white-space:nowrap">99-23+;</FONT><FONT STYLE="font-size:8pt">&nbsp;</FONT>0.664%</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2031 Notes: <FONT STYLE="white-space:nowrap">99-16+;</FONT><FONT STYLE="font-size:8pt">&nbsp;</FONT>0.926% <BR></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Spread to Benchmark Treasury:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2027 Notes: +67 basis points (0.67%)</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2031
Notes: +95 basis points (0.95%)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Yield to Maturity:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2027 Notes: 1.334%</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2031 Notes:
1.876%</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Interest Payment Dates:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2027 Notes: Semiannually on February&nbsp;21 and August&nbsp;21, commencing on February&nbsp;21, 2021. The interest payable on
February&nbsp;21, 2021 will include interest deemed to have accrued from and including August&nbsp;21, 2020 to, but excluding, December&nbsp;16, 2020, totaling $3,114,583.33. Such accrued interest shall be paid by the purchasers of the 2027
Notes.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2031 Notes: Semiannually on February&nbsp;28 and August&nbsp;28, commencing
on August&nbsp;28, 2021.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Record Dates:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2027 Notes: February&nbsp;6 and August&nbsp;6</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2031 Notes: February&nbsp;13 and August&nbsp;13</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Optional&nbsp;Redemption&nbsp;Provisions:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>2027 Notes</U>: Prior to June&nbsp;21, 2027 (two months prior to the maturity date), <FONT STYLE="white-space:nowrap">make-whole</FONT>
call at any time at the greater of 100% or discounted present value at Treasury Yield plus 15 basis points. On or after June&nbsp;21, 2027, redeemable at a redemption price equal to 100% of the aggregate principal amount of the 2027 Notes being
redeemed.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><U>2031 Notes</U>: Prior to November&nbsp;28, 2030 (three months prior to
the maturity date), <FONT STYLE="white-space:nowrap">make-whole</FONT> call at any time at the greater of 100% or discounted present value at Treasury Yield plus 15 basis points. On or after November&nbsp;28, 2030, redeemable at a redemption price
equal to 100% of the aggregate principal amount of the 2031 Notes being redeemed.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Change of Control:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Upon certain change of control events, the Issuer will be required to make an offer to purchase the Notes in cash at a price equal to 101% of their aggregate principal amount.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><FONT STYLE="white-space:nowrap">Joint&nbsp;Book-Running&nbsp;Managers:</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BARCLAYS CAPITAL INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GOLDMAN SACHS&nbsp;&amp;
CO. LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SECURITIES LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RBC CAPITAL MARKETS,
LLC</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">TRUIST SECURITIES, INC.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><FONT STYLE="white-space:nowrap">Co-Managers:</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES, INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CITIGROUP GLOBAL MARKETS
INC. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CREDIT SUISSE SECURITIES (USA) LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MIZUHO SECURITIES
USA LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WELLS FARGO SECURITIES, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">LOOP CAPITAL MARKETS
LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MUFG SECURITIES AMERICAS INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. BANCORP INVESTMENTS,
INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FIFTH THIRD SECURITIES, INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">PNC CAPITAL MARKETS LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SANTANDER INVESTMENT SECURITIES INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SMBC NIKKO SECURITIES
AMERICA, INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BNY MELLON CAPITAL MARKETS, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ICBC STANDARD
BANK PLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KEYBANC CAPITAL MARKETS INC.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TD SECURITIES (USA)
LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">AMERICAN VETERANS GROUP, PBC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">GREAT PACIFIC SECURITIES</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">R. SEELAUS&nbsp;&amp; CO., LLC</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>CUSIP Numbers:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2027 Notes: 126650 DM9</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">2031 Notes: 126650
DQ0</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>U.S. Federal Income Tax Considerations:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a summary of the material U.S. federal income tax considerations relevant to the ownership and disposition of the Notes, see the
discussion under the caption &#147;U.S. Federal Income Tax Considerations&#148; in the Preliminary Prospectus Supplement. The discussion below is meant to update and supplement such summary in the Preliminary Prospectus Supplement and is subject to
the same limitations and qualifications set forth therein. To the extent the discussion below is inconsistent with such summary in the Preliminary Prospectus Supplement, the discussion below supersedes the relevant disclosure in the Preliminary
Prospectus Supplement.</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Qualified Reopening.</I> The Issuer intends to treat the
2027 Notes offered hereby as issued pursuant to a &#147;qualified reopening&#148; of the Initial 2027 Notes. For U.S. federal income tax purposes, debt instruments issued in a qualified reopening are deemed to be part of the same issue as the
original debt instruments. Under the treatment described in this paragraph, the 2027 Notes offered hereby will be deemed to have the same issue date and the same issue price as the Initial 2027 Notes.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Pre-Issuance</FONT> Accrued Interest. </I>A portion
of the price paid for the 2027 Notes will be allocable to interest that accrued from August&nbsp;21, 2020, prior to the date the 2027 Notes are issued (the <FONT STYLE="white-space:nowrap">&#147;pre-issuance</FONT> accrued interest&#148;). In
accordance with applicable U.S. Treasury regulations, for U.S. federal income tax purposes, the Issuer will treat the 2027 Notes as having been purchased for a price that does not include any <FONT STYLE="white-space:nowrap">pre-issuance</FONT>
accrued interest. If the 2027 Notes are so treated, the portion of the interest received on the first interest payment date equal to the <FONT STYLE="white-space:nowrap">pre-issuance</FONT> accrued interest will be treated as a <FONT
STYLE="white-space:nowrap">non-taxable</FONT> return of the portion of the purchase price paid that is allocable to the <FONT STYLE="white-space:nowrap">pre-issuance</FONT> accrued interest and will not be treated as a payment of interest on the
2027 Notes. Prospective investors should consult their tax advisers regarding the <FONT STYLE="white-space:nowrap">pre-issuance</FONT> accrued interest.<I> </I></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Ratings*:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[Intentionally Omitted]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">*&#8195;&#8201;&#8201;<B>Note: A securities rating is not a recommendation to buy,
sell or hold securities and may be subject to revision or withdrawal at any time</B><B>.</B></P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ICBC Standard Bank Plc is restricted in its U.S. securities dealings under the United States Bank Holding
Company Act and may not underwrite, subscribe, agree to purchase or procure purchasers to purchase Notes that are offered or sold in the United States. Accordingly, ICBC Standard Bank Plc shall not be obligated to, and shall not, underwrite,
subscribe, agree to purchase or procure purchasers to purchase Notes that may be offered or sold by other underwriters in the United States. ICBC Standard Bank Plc shall offer and sell Notes constituting part of its allotment solely outside the
United States. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Changes to Preliminary Prospectus Supplement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The number of series of notes to be issued in the offering increased from one series (as disclosed in the Preliminary Prospectus Supplement) to two series,
consisting of 1.300% Senior Notes due 2027 and 1.875% Senior Notes due 2031. The 1.300% Senior Notes due 2027 constitute a further issuance of the Initial 2027 Notes. Upon settlement, the 2027 Notes will have the same CUSIP and will trade
interchangeably with the Initial 2027 Notes. We expect the 2027 Notes to be fungible for U.S. federal income tax purposes with the Initial 2027 Notes. The interest payable on the 2027 Notes on February&nbsp;21, 2021 will include interest deemed to
have accrued from and including August&nbsp;21, 2020 to, but excluding, December&nbsp;16, 2020, totaling $3,114,583.33. Such accrued interest shall be paid by the purchasers of the 2027 Notes. Immediately after giving effect to this offering, the
total amount outstanding of our 1.300% Senior Notes due 2027 will be $2,250,000,000. The information in the Preliminary Prospectus Supplement is deemed to have changed, <I>mutatis mutandis</I>, to the extent affected by the additional series of
notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We may increase or decrease the total aggregate principal amount of Tender Offer Notes and the aggregate principal amount of each of the 2023
Notes, 2025 Notes and 2028 Notes that we may purchase in the Tender Offers as specified in the Preliminary Prospectus Supplement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following paragraph shall replace the first paragraph under the heading &#147;Underwriting&#151;Other Relationships&#148; </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">in the Preliminary Prospectus Supplement: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">From
time to time, certain of the underwriters and/or their respective affiliates have directly and indirectly engaged, and may engage in the future, in investment and/or commercial banking transactions with us for which they have received, or may
receive, customary compensation, fees and expense reimbursement. Barclays Capital Inc., BofA Securities, Inc. and Goldman Sachs&nbsp;&amp; Co. LLC will act as dealer managers for the Tender Offers. To the extent any of the underwriters or their
affiliates own notes that are the subject of the Tender Offers they may tender such notes pursuant to the terms of the Tender Offers. A member of our board of directors is an officer of Bank of America Corporation, an affiliate of one of the
underwriters. An affiliate of one of the underwriters, BNY Mellon Capital Markets, LLC, is acting as Trustee, Registrar and Paying Agent in the offering. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Capitalized terms used but not
defined herein have the meanings given to them in the Preliminary Prospectus Supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Issuer has filed a registration statement (including a
prospectus and preliminary prospectus supplement) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus and preliminary prospectus supplement in that registration statement, and other
documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at </B><B><I><U>www.sec.gov</U></I></B><B>. Alternatively, you
may obtain a copy of the prospectus and the preliminary prospectus supplement from Barclays Capital Inc. by calling toll-free <FONT STYLE="white-space:nowrap">1-888-603-5847,</FONT> Goldman Sachs&nbsp;&amp; Co. LLC by calling toll free <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-866-471-2526</FONT></FONT></FONT> or J.P. Morgan Securities LLC by calling collect at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-212-834-4533.</FONT></FONT></FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS
COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SIGNIFICANT SUBSIDIARIES </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used
in the Underwriting Agreement, the &#147;Significant Subsidiaries&#148; of the Company are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="27%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Jurisdiction of Organization</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>% Owned</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Liens/Encumbrances</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Aetna Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Pennsylvania</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">None</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CVS Pharmacy, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Rhode Island</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">None</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Caremark, L.L.C.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">California</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">None</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CaremarkPCS Health, L.L.C.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Delaware</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">None</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Caremark Rx, L.L.C.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Delaware</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">None</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CVS Caremark Part D Services, L.L.C.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Delaware</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">None</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Omnicare, Inc.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Delaware</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">None</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">SilverScript Insurance Company</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tennessee</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">100%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">None</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The Company is a corporation validly existing and in good standing under the law of the State of Delaware. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. The Company (a)&nbsp;has the corporate power to execute, deliver and perform each Opinion Document to which it is a party and (b)&nbsp;has
taken all corporate action necessary to authorize the execution, delivery and performance of each Opinion Document to which it is a party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. No authorization, approval or other action by, and no notice to or filing with, any United States federal or New York governmental authority
or regulatory body, or any Delaware state governmental authority or body acting pursuant to the General Corporation Law of the State of Delaware is required for the due execution, delivery or performance by the Company of any Opinion Document to
which it is a party, except as have been obtained and are in full force and effect under the Securities Act or the Trust Indenture Act of 1939, as amended (the &#147;<U>Trust Indenture Act</U>&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. The Underwriting Agreement has been duly executed and delivered by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. The Indenture has been duly executed and delivered by the Company and is the legal, valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. The Notes have been duly executed by the Company and, when authenticated by the
Trustee in accordance with the Indenture and delivered and paid for as provided in the Underwriting Agreement, the Notes will be the legal, valid and binding obligations of the Company, enforceable against the Company in accordance with their terms
and entitled to the benefits of the Indenture. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. The Company is not required to register as an investment company under the Investment
Company Act of 1940, as amended. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. The Indenture has been duly qualified under the Trust Indenture Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. The statements in the General Disclosure Package and the Prospectus under the caption &#147;Description of the Notes&#148; and
&#147;Description of Debt Securities&#148;, in each case, insofar as such statements constitute summaries of documents referred to therein, fairly summarize in all material respects the documents referred to therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. The description of the U.S. federal income tax consequences set forth in the General Disclosure Package and the Prospectus under the
caption &#147;U.S. Federal Income Tax Considerations,&#148; insofar as such description constitutes a statement of U.S. federal income tax law or legal conclusions and subject to the limitations and conditions described therein, is accurate in all
material respects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. The execution and delivery by the Company of each Opinion Document to which it is a party do not, and the
performance by the Company of its obligations thereunder and the consummation of the transactions contemplated thereby will not, (a)&nbsp;result in a violation of the Company&#146;s Amended and Restated Certificate of Incorporation or Amended and
Restated <FONT STYLE="white-space:nowrap">By-Laws,</FONT> each as amended through the date hereof, (b)&nbsp;result in a violation of Generally Applicable Law or any Specified Document or (c)&nbsp;result in a breach of, a default under or the
acceleration of (or entitle any party to accelerate) the maturity of any obligation of the Company under, or result in or require the creation of any lien upon or security interest in any property of the Company pursuant to the terms of, any
Specified Document. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Subject to the limitations set forth in the immediately preceding paragraph, we advise you that, on the basis of the information we gained in the course of
performing the services referred to above, in our opinion, each of the Registration Statement and the Prospectus (other than the financial statements and other financial data contained or incorporated by reference therein or omitted therefrom and
the Trustee&#146;s Statement of Eligibility on Form <FONT STYLE="white-space:nowrap">T-1,</FONT> as to which we express no opinion) appears on its face to be appropriately responsive in all material respects to the requirements of the Securities Act
and the applicable rules and regulations of the Commission thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We further advise you that, subject to the limitations set forth in the second
preceding paragraph, on the basis of the information we gained in the course of performing the services referred to above, no facts came to our attention which caused us to believe that (i)&nbsp;the Registration Statement (other than the financial
statements and other financial data contained or incorporated by reference therein or omitted therefrom and the Trustee&#146;s Statement of Eligibility on Form <FONT STYLE="white-space:nowrap">T-1,</FONT> as to which we have not been requested to
comment), as of the date of the Underwriting Agreement, contained an untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading; (ii)&nbsp;the
General Disclosure Package (other than the financial statements and other financial data contained or incorporated by reference therein or omitted therefrom, as to which we have not been requested to comment), as of the Applicable Time, contained an
untrue statement of a material fact or omitted to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; or (iii)&nbsp;the Prospectus (other than the
financial statements and other financial data contained or incorporated by reference therein or omitted therefrom, as to which we have not been requested to comment), as of the date of the Final Prospectus Supplement or the date hereof, contained or
contains an untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT D </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">December&nbsp;16, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">745 Seventh Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">200 West Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10282 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10179 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representatives of the several Underwriters </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">named in Schedule I to the Underwriting Agreement referred to below </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I am Vice President,
Assistant Corporate Secretary and Assistant General Counsel of CVS Health Corporation, a Delaware corporation (the &#147;<B>Company</B>&#148;), and have acted in such capacity in connection with the Underwriting Agreement dated December&nbsp;7, 2020
(the &#147;<B>Underwriting</B> <B>Agreement</B>&#148;) between the Company and you, as Representatives of the several underwriters named in Schedule I thereto (the &#147;<B>Underwriters</B>&#148;), under which you and the other Underwriters have
severally agreed to purchase from the Company $750,000,000 aggregate principal amount of the Company&#146;s 1.300% Senior Notes due 2027 (the &#147;<B>2027 Notes</B>&#148;), $1,250,000,000 aggregate principal amount of the Company&#146;s 1.875%
Senior Notes due 2031 (the &#147;<B>2031 Notes</B>&#148; and, together with the 2027 Notes, the &#147;<B>Notes</B>&#148;). The Notes are to be issued pursuant to the provisions of an Indenture dated as of August&nbsp;15, 2006 (the
&#147;<B>Indenture</B>&#148;) between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.), as trustee. The 2027 Notes represent a further issuance of the Company&#146;s 1.300%
Senior Notes due 2027 issued in an aggregate principal amount of $1,500,000,000 on August&nbsp;21, 2020. Capitalized terms used herein and not otherwise defined herein have the meanings given to them in the Underwriting Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I have examined originals or copies, certified or otherwise identified to my satisfaction, of such documents, corporate records, certificates
of public officials and other instruments as I have deemed necessary for the purposes of rendering this opinion. I have assumed the capacity of all natural persons and the genuineness of all signatures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, I am of the opinion that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. The Company has been duly incorporated and is duly qualified to do business as a foreign corporation in good standing in all jurisdictions
in which its ownership or lease of property or the conduct of its business requires such qualification, except to the extent that the failure to be so qualified or in good standing would not, individually or in the aggregate, have a Material Adverse
Effect; each of the Company&#146;s Significant Subsidiaries has been duly organized and is a validly existing corporation or limited liability company, as the case may be, in good standing under the laws of the jurisdiction of its organization, with
corporate or limited liability company power and authority, as the case may be, to own, lease and operate its properties and to conduct its business as described in the most recent Preliminary Prospectus and the Prospectus; and each Significant
Subsidiary is duly qualified to transact business as a foreign entity and is in good standing in each other jurisdiction in which it owns or leases property of a nature, or transacts business of a type, that would make such qualification necessary,
except to the extent that the failure to be so qualified or in good standing would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. All of the outstanding shares of capital stock of, or other ownership interests in, each of the Company&#146;s Significant Subsidiaries have
been duly and validly authorized and issued and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and the shares of capital stock of, or other ownership interests in, each Significant Subsidiary owned by the Company,
directly or through subsidiaries, are owned free and clear of any security interest, claim, lien, encumbrance or adverse interest of any nature. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. The execution, delivery and performance of the Indenture and the Underwriting Agreement
and the consummation of the transactions contemplated therein have been duly authorized by all necessary corporate action on the part of the Company and do not and will not conflict with or result in a breach or violation of any of the terms and
provisions of, and do not and will not constitute a default (or an event that, but for the giving of notice or the lapse of time or both, would constitute an event of default) under, or result in the creation or imposition of any lien, charge or
encumbrance upon any material assets or properties of the Company or any of its subsidiaries under, and neither the Company nor any of its subsidiaries is in violation of (A)&nbsp;the charter, <FONT STYLE="white-space:nowrap">by-laws</FONT> or other
organizational documents of the Company or any Significant Subsidiary, (B)&nbsp;to my knowledge, any statute, rule, regulation, order or decree of any governmental or regulatory agency or body or any court having jurisdiction over the Company or any
subsidiary or any of their properties, assets or operations or (C)&nbsp;to my knowledge, any indenture, mortgage, loan or credit agreement, note, lease, permit, license or other agreement or instrument to which the Company or any subsidiary is a
party or by which the Company or any subsidiary is bound or to which any of the properties, assets or operations of the Company or any subsidiary is subject, except, in the case of clauses (B)&nbsp;and (C), for such breaches or violations which
would not, individually or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. Except as described or incorporated by reference in the
most recent Preliminary Prospectus and the Prospectus, there are no pending actions, suits or proceedings against the Company, any of its subsidiaries or any of their respective properties, assets or operations that would, individually or in the
aggregate, have a Material Adverse Effect, or could materially and adversely affect the ability of the Company to perform its obligations under the Underwriting Agreement, the Indenture or the Notes and no such actions, suits or proceedings are, to
my knowledge, threatened. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I am a member of the Bar of the Commonwealth of Massachusetts and the foregoing opinion is limited to the laws
of the Commonwealth of Massachusetts, the federal laws of the United States of America, the General Corporation Law of the State of Delaware and the Delaware Limited Liability Company Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is rendered solely to you in connection with the above matter at the request of the Company. This opinion may not be relied upon
by you for any other purpose or relied upon by or furnished to any other person without our prior written consent. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Very truly yours,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Thomas S. Moffatt</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Vice President, Assistant Corporate Secretary and</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assistant General Counsel</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to General Counsel&#146;s Opinion</I>] </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cvs-20201207.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 12/10/2020 1:32:08 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2019-01-31"
  xmlns:cvs="http://CVS/20201207"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:sic="http://xbrl.sec.gov/sic/2011-01-31"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://CVS/20201207"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2019-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2011-01-31" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20201207_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvs-20201207_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cvs-20201207_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 12/10/2020 1:32:08 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cvs-20201207_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2020-7 Build:20201110.1 -->
<!-- Creation date: 12/10/2020 1:32:08 AM Eastern Time -->
<!-- Copyright (c) 2020 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cvs-20201207.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g48081g1208231322691.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g48081g1208231322691.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  3 &@# 2(  A$! Q$!_\0
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M?W:AADX)&[)!YZ#BL&UT/5M(T3PC8W>D7EXUOJK7MPD,8D6",I(H4Y.,Y<'
M]_2MSQ3IDLOC'0H[#1[@0+!=13W=O OEQF9-BDD$'@C)]!75'9'SE=1562B[
MJ[V->'X@Z%/=QQJUV+267R(M0:U<6LDF=H59<8.2, ]#ZT^_\=Z+I^H7%I)]
MLE6T.+RY@M7DAM3C.)' P#C\N^*X&P\.WTFAV'AS4+7Q;+<1"*WG@^T(EB%0
MCYUEVD;/E#!1\W08[UT%C)J?AJSUK0V\/7M_-<W=S/:3P1AH;E9F+#S')^0K
MNVG=V QFF8DC>+VNO$>DZEI]U>RZ+>:;=3FU-MRYB*[708W'.X]\'BL__A/K
MFYLO!VOR-=V=M?7#V]W9);EA*?)=EV KN;Y@H!'!IGA[3-6LT\$//I%Y']EL
M+C3[D>6,P2-L"EAG[GRGYJBTJWU2VTWP%:3Z#J@DTBY=;S]R"J?NGCW YY&7
M!R.P/I0!Z#H?B.QU]+@6RW$-Q;,%N+6ZA,4T1(R-RGL1R#T-%8VF+=K\3]<G
M?3KQ+2>RMHH[EH\1,T9D+<Y_VQCCUHH ["BBBCJ#"BBB@ HHHH **** "BBB
,@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d48081d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cvs-20201207.xsd" xlink:type="simple"/>
    <context id="duration_2020-12-07_to_2020-12-07">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000064803</identifier>
        </entity>
        <period>
            <startDate>2020-12-07</startDate>
            <endDate>2020-12-07</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2020-12-07_to_2020-12-07"
      id="Hidden_dei_EntityRegistrantName">CVS HEALTH Corp</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2020-12-07_to_2020-12-07">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2020-12-07_to_2020-12-07"
      id="Hidden_dei_EntityCentralIndexKey">0000064803</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2020-12-07_to_2020-12-07">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2020-12-07_to_2020-12-07">2020-12-07</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2020-12-07_to_2020-12-07">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2020-12-07_to_2020-12-07">001-01011</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2020-12-07_to_2020-12-07">05-0494040</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2020-12-07_to_2020-12-07">One CVS Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2020-12-07_to_2020-12-07">Woonsocket</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2020-12-07_to_2020-12-07">RI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2020-12-07_to_2020-12-07">02895</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2020-12-07_to_2020-12-07">(401)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2020-12-07_to_2020-12-07">765-1500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2020-12-07_to_2020-12-07">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2020-12-07_to_2020-12-07">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2020-12-07_to_2020-12-07">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2020-12-07_to_2020-12-07">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2020-12-07_to_2020-12-07">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2020-12-07_to_2020-12-07">CVS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2020-12-07_to_2020-12-07">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2020-12-07_to_2020-12-07">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140113926080936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 07, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CVS HEALTH Corp<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000064803<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec.  07,  2020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">05-0494040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One CVS Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Woonsocket<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">RI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(401)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-1500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CVS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M'U#4^"[%VAY<$]^4N=9OOC".;UK4$XE$1,Y+</AY%R.1)%X)./[:B[;*=_K
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M%S?W1:[-XPFNWPQP>'3^ 5!+ P04    " !OAHE199!YDAD!  #/ P  $P
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ ;X:)49E<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    " !OAHE1"7SQHR@$   U$   &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ ;X:)48.II0/4 0
M,@8   T              ( !:PP  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" !OAHE1EXJ[',     3 @  "P              @ %J#@  7W)E;',O+G)E
M;'-02P$"% ,4    " !OAHE1'#AEZC\!   \ @  #P              @ %3
M#P  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ;X:)420>FZ*M    ^ $
M !H              ( !OQ   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ ;X:)4660>9(9 0  SP,  !,              ( !I!$
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  [A(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d48081d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d48081d8k.htm">d48081d8k.htm</File>
    <File>cvs-20201207.xsd</File>
    <File>cvs-20201207_lab.xml</File>
    <File>cvs-20201207_pre.xml</File>
    <File>d48081dex11.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>g48081g1208231322691.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d48081d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d48081d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvs-20201207_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvs-20201207_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cvs-20201207.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cvs",
   "nsuri": "http://CVS/20201207",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d48081d8k.htm",
      "contextRef": "duration_2020-12-07_to_2020-12-07",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d48081d8k.htm",
      "contextRef": "duration_2020-12-07_to_2020-12-07",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://CVS//20201207/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-20-313889-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-20-313889-xbrl.zip
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M>__1X_\AA*^$\XV%3QU<;Y)M>0M6*M>Y"+NV>3LC,*5)2WG4=W\H,R]BX*V
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MVE"FM6&6CIQ%ZDWIHWV>9IHJC0+D7KS\PN$DYE1Y@3><9,1QD(P"F*&:CTP
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M,T&F@1)XCE\;/E_@1.)MFNASB7I*UEVH?/_*(<$JC54@U%A/ISUA.%KCFK8
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M*7-^DG-'+E"$%$BJ L?/BO* +<!4K9^R%23MU/$>=FW)=:J==Q_A@2TM0QM
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M:DK$EVL>K32I>:Z+N]=JXTA,5=7="QLUS*.5\HKPUW:.,_<XMTH>JU6)"Q1
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M-8=#JXF)!NE=@0FD^^ID7B E[*  P>3R4:E!;.GAXB^,55$\YDP'&0& 'Z3
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M[J7*6WS=YFUF6D<Y/W'1KA58=T=?VRA%;[1N,J^H9@GKY3QOZ8NF$F=J(+5
M05UD9>V[%NX%4K.HCT[O>U1UA!!JE#'&#ANWH1J7'!U7TUO3S-T74'A(7S>=
M0"S"0!:MF!E;R:6N)JAC7((=<(FJM"G8M?(%KYPNIES&SJ_$-9XU,DKB'9#U
MBCXGD1AJ.,JI12!/>-WFQJ_JA5K%:1Z.7Q=0)"+EEJQ8N'LI]FL=_H =E2>]
M3O-\89 \Z9ZR425S475?IJ!Y,JT[>1S4C8:Z79@SED#2!^#)4E#LE-^28C8/
MTR1)DS6S!PK<Q$T454==J '!U$S:VWP12!9FP4/6).,[&WAWR@ =9!9I+$3V
M>:HI_[:$7$::L%0?]4@V) *ND26(7:4YWXY*.1)B[3](\?E@&!6$B5L2*1&9
M:EBL../VKG>54N=:"LS8T_6]4BD[A4S8ZL?E-.WZ+,>VLH]%D00E]]YDJWBS
MSJ\TX*;:>U>.^;]<]SJY1YU>*B7Y?)RH+P97@UGODC(PR^.OM:9<\65Q+X.E
M;0_2"%;*:U3A%^Y((Q%"20/B0&O0="Q(73.+2J[L0G/T1Y=*KT@J7<BVZ[+7
M+Z!M,O2 L*IV2_$JAV@X!=2031-X_9R28KCI,J+Z=XD=!KFL*A-N.3]>IT8-
M73P'IW:(P5F(T_B4_)-SB0 9-!.*K/GSL1&*E#)X!>'&KE*9A<1@L4\70%-F
M3TZ@4DV[T%7N[>IZ0Y>P+1@/!9SJBP?<>06Q!8. 6E-3(,ZM^M:FD8CHX20>
MPCJ& SAMV%?;T$AU<$[M9+5 ZY4.L\]E*R4W74DD^+78QS6,(E>=24.NUW@I
M64*/GXZ.:R=4;;O;V,LOYX<S[R6]0Y"89N4\;=;L '(@R8Q,*1Y:A&!? Q.^
MHMQ1_#2^2A/!,H*34[K$LZY0NQ6-@)@QNA%/54<_'HZ\Z='9U>:&:-'9=70=
M$'[809AA5BYF8HF33G<P%IV#-1HG>]<5)S6K:?K".0@QO@T/PQ7K^@4EXJU[
MGU#E)MWZHN:UM/ YS4XE/-B0REKYJBD3<I1\S$<A:33"I4&$KDE,P'I]MN X
MP(]L\3+(!K%X'X/R,0<V@LF"<=QT[%/5]L3*2U"J[H(1YD<_D)N;1$.?Z4P*
ML1S-X2JXVA8GUE'4FZLP015;G? H=[H7-SB/S?JA=-'GO]SJDM0U>; ^D>:4
M]]#LB1#2  [N-UQMT# IK0@QB8(D5[ZV"K2;MKH+[S2!C[]WO4/$YO>]/U+L
M=]/_&L(DSZ]2V,?C/$:"V=C:>[7C6V]()H@KX:V\V-A<G6^]O-S=67NYM_?2
M%PVPW>JHQGVORZ" S* T//O]E]@KK[#R"M: XSW <E>+,C&F$7!JX'Z0]6.$
M@S\(QA&:%L=)?]WW7K[8 9Z!2L*5U\&-4;BRYB^P2C8V7U6WY+6WLOMB=X$]
MV=M^L;:WN;VM]L2SMJ0[!>T!,6B<&@??^Y#& SA$7C?H7^4V".%!NNZ=G!SX
MWM;&AO<', /0DPO8@J)AZ%M[6[[]0J>4XA#3V0O-A_]K_0SQ)Q%_VW;LT.NV
M][:]3\$@0AV^0YVC&EZX^;)^K;8VMQ9<J]V-O<VZM3HFYD>C_9 !ZX.9Z]4[
M#/.OZPZ@2ZU#-Y!.I!D*6LG,UC ^ODK8\G6><&:IH4S9:<9L=ZZ>7:.<_\#P
M@2^>PT)+%(Q; HQD@MGO==9_S]'#C8Y5\M H?Y-2%ST&G4"J2X(1%Z23DW>6
M^QJ+@A@7NV3" Q_6-CR[?>\"*,8N A@@1EU5R!XV/8[3&ZJ-&$:7U 7&U,JH
M3G2<L17"A?P9JV=0CPE8BZY,H-UZH!FH[ZI8=AS +VY2,RYJ2J0\F'A-#[1!
MS&#!L!9FM1<W8:APW,Q=.BIEQ=HTU^)YG5%$NEN0,?=O$1+=JS1#'#WJ5Z#"
M:&=A$F L:C\:Y+("C[;=IDQ;4H0P0_N6-2Z+.#5<;[Y?3J\H&0%@FOH>!O_P
MOY?P7X(Q(6,5,_,JFLSC&UO;K"@'JH[A/!3 HZMH;!E96IWLZ^08RS@25W%#
M K1.F=($+5#GQMA)'81X!7]?&ZLJIW*Q"J]\=.*0*5>FD1<0!OH-NXY08R@S
M2\1%!M42W;9._3)J[>K0Z)0A/=*,DH==:%'\+0?+CDL,,0TH2B=Y+$755C*Y
MLI[*$WQM7%U)"J=\,.E' 8\K8.!Y>^">/3X;V]$LI0JSE1+G#&]QB9DO:[?X
M9KZ2ULQI$E--JQ*W=,!Y<)BLQ"N:^Y02E$FNH5[:BAFD69=O>8]4VXMZ#&F5
MOF:9K:%J\:(ICK-IW/B2AO:PU]+=;-/R\S;KYMG+!J<:^2AI>_3&-*8_N7(E
M(T!/EPJYE)W@B$;Y6APFES#I)+Q,$2,5KZHT;!E,M(_""0[6X8@XA3_6'*WT
M UIQQ1A13#0\WZGMD^I@]N2^\5SHUBJE\/*Y,2D+44$/DKI!A'DALQE$N*,J
M[5&0LZU9N/HW#@93JP()NKB9^D[V@7ZAJDVJ#+E,>R0K,J7?F#,*B]50 H)%
M$$*0C\_?7V!Z__&[<VZ^9)\5:FO2Q;T$4CS'/#*.6*.9-@J1]S]ZN@C(QN/$
M.,\]C>?EX$!A+N0!-GH!NCM"785/&,-4Y%930VD@)G#$HHL$<R8NP26T]C7)
M57$DJYY[Q7@5Y9:.C<>E\U;VAG6O+E!3V,O:BX'I%E**II*3U<@8H\:YRT+F
MF#U)+VJ>@"1IUL["YZS#2US]Q#AGXN#&2E:Q^L-P90HG]-;]OOZ6J$Q([;$1
M9.Y.:Q&[1;W]CP>4?-)1+*P62J=*F9Y-F.W6HI1Y*&'L<RXPK2,FGH<H2N$W
ME#0H5A1[JXPM<!"R6*4RMU'YJ7=)!6"951,IQ0&E\?0U1>H'&/W?GANZR^92
MY+))[;&Y62E\K8/*8AJ\>'V' 2VU02];8F_WWU6H^.UO^^_$*KL2MJ.2KT#!
MC2X38SY947AX4E!] N)P^E9*64^$.ZC'"MZMCUU:-=@TF$I;1"T'Z_C@W9=O
MO,V]%YLK7^]4_?\P*^:R!&NY<)FD!$8:"PQ3]#G TCWY?H-M 2>$Y]"7"9"M
M/Y7!!TI#PCV-3.]%M8$+[-O!^OOU\W5RB>#&;>ULK>]M :]]\_23KYD]-GY;
MVMQ!J:3)*Z)]\7)]FV8.C.GI)U\S^_?=X^5,OMW2.Z\FO[VWM8[[OOZ]G%A'
M5"W,W_2:E%@8,K4%SX*LB'T@-GTDCBTD#%PG^!CD5D'B#^RKWWGVU3\"+<^S
MW$K22-FJ=AI5NZ4:6AZ&U'06E&'Q7#'6H,Z-, CHB+(TB2\-&IC)-S;.H0MT
M'7O'QTH'.TP'@[7W\."OWA]X=CAB"$/5_<0.X-G80!W=N858SK<;PA/D%^R0
MV_2,G8+*3UI-\VC&-B8]N1>Q>]*DU]=&K<O^O;('A: +,-"19GEE'&H93=*^
M%4H72 HT E0N*K4+L88J1<X4-E"YTB9!R_$%-2=SUGFZ56IEM>.2,H?)IY]-
MF!E?DJM(9W-*=QK"_!8/K23)5@H>H]P$/'RW;-$4)A-F#[KS1^%@:NH*F<33
M<I/?^A09O;!68A [QIZ 0G>)0@]1DFNW#Q(J?"F,A#_L2RLA[S"86K_OJ=_7
MR3Q_GV;57O7-";EH5,AS,:NT7D,>!)09:!4Z-C0M1@?:.$SLWL1.<Z+*PRP?
M*ZIX[*&6;KW_#FO:0W@((<B$JP=Q$#U)YA)WKOE 9B^U30UNFOE+SS&0?563
M(Z>F3B\IV]!=93"K>3_!E+ELYB/C+5IAYROY1F5?XRY&B0 H#PE8)KD.DTA5
M,9L:=F):G*,?"L)*P1B;$C3B3%3N69*B!UJ +MHM7664&;57Q1C*N=&/[\[E
M7.X#;FZ-LZ@7/N+_$54678\)I92,$+&@;]WM*^V@W>*C0V1E!5.Q6ROPQ@C!
M<FA!X]B _A3I)6,"E._"UYEHW\AJ?[?NV8,W$3U*@82Q7D>!2>'Q&2,J2Y.H
M3YE9=I ;3[WU,\Z5HYC:NIL:Q]-0M)VC+FB!7"\VQ#RF#1\#NA$I(T?F81?H
M9 TD5YOZ%^&3K NZZFVJ40P>,Q<$N0(Q$JY?KOO>S<W-.K;YPO&N Z-:-3<X
M*68C6-ETH+VRUJ9QC8Q:L)H*?8.A-)C(.;@&-79@L-7# 6>0PFWTBY4P2D@1
M7+JK.?XL.F_LO'8?0^+_4L@"$UL'[&U'2T#P&0BX*48A/BR\7@S\_8V]'>QO
MP5/Q_WY<.VKWV8Y:'M,\8X@OR58B8"P\?"HC ?C[A$4M'!U$4VY@E35JCW2<
M83>?ZG8B2" QX:KETB_122YN#-PWF0"5\V?-?\N0<2-5VU1,&R2;2$KO+TAG
M;R\Z^R='WL'1R4GWK'-P_/G#WW_9^(4^GW4.#]5GH8072 C[I^>'1^?TM8R*
MOUD#ZCGIG'6/7JL_9NY/>3.1.)C"+\[?R1^'ZL4O?_T%CL+%H?GA=YD*3];0
MJKK0O?_5EOH>_G-NO4E-P3HI$2$5O0ZN4^"/MYQ":7"P,;"6I[BTG_&<O?L=
MT_U!20,BF6+QGF_&Y(['>K#UW(]'QQ\^7L L=]W'-CWED6:%2>8?CSHG%Q_A
MZ_.ST_/.Q?'IYSM/S=G VBEO/<64W^U/7]LC*U&@/FK5*^CNA1G?)G[5HQZ]
MYJMO:)_#-/ZV0?]W2T[X6_Z;=Q!D:>QUUKW#\',0A\02'G\-[[& GT&??%V=
MQH\T!7*2O?:Z8+N I*EILWV!R"N@SF0VKX)_D$F_8XW@D;4QK6%Y9ZB*%186
M$@H]+=N,XO7755V>Q>5C"Q9=ETCF4!^]C_A!>S&P([AD14O1)1L*"/[_%Q"L
M^YWS@Y/.GUWOH'-V?-$Y\8X_'ZP_R]7O2J[N!UDOR +O$U831"$8H3^J:*V;
MR8\T"Y&NGX(DN*0B?P$D^DNP@@^G)X>?.I^];N?@8]>ISCNEZKQGKO!=<87.
M(!AY%^O>!U"/DA]6V2[/XD>:P5^:&W#9[.GY!^0(1P=?SH\OCH^ZSWS@N^,#
MW73D[5\%11'TKX)L.@U^5%90,Y$?:1+"#8Z^A?T)A3JJ[, 8V@]H8F-V<!TZ
M6*6VN\X=3&6V%-9[^^5=MW\5(N"G=_SVMR_O*%0*QOF,&.ZSB^![BV[<9>'%
M=?]V_UWWX./1X9>3(^_8PS2+Y44*;NWGX"5\*$='F>1F^3UV%W5\;+F.C]E_
M+_5A#\$R]VHXIAKCY],_SCL.:7@N,7BUM%D2A>L;>&5)&@ZB?!P'T]>42;6&
M6$*E0<V9 )&QBSS =#R?T3>S>S5O2VTI49!:A_E3I &>*4!(?F>'4"'?[I^_
M2X>FVG%K8^LE%YKB+Y)LHH#;>5IWD5U//VFO:;[;F\N8;]F_N/^!N/3??_E;
MOQ^&P^$OCZ!6W/9HV,F]N( HB^Q ]9KZ\E:*02U:T)(.P[O_F$4TKF1YM>%C
M>@S\S[Z'N<C#4>YM1KBY<\<A/JZV^GV0U3Q4IV<*>R@*^WE963.HUS.U/?.S
M^]'6^?Z!EI"?@NQKB+FL3T-9+[?]G>^<LK:V[C;$9SZ&M':13:*\L%B8_U1*
MV4]":C\+8>VGP\[W0%;;W[UL?%;$[D-G!T!>EUDZ&7L?XK1G).8SO3TDO?TT
MU)6%@PC$(PC)W&G+M/*EVUE](J7LYR"QGY>E?8K^/;E*;6H#8GNFM6=V=F_*
M^B.,X]Q[#\].'=WLF;:>^=CRJ>TD3<=E1\83D=I=+;='/ POGVW+A07DE_<?
MG!Z9HS"+^L&3Z?P_!W7]O(R,RNSW@Z2?9F.K7\;3.35^#H+[6<CK?30LKA#F
M(AM\#QZSS9WO72W;NN,(G[D9809\KH27GD@K^SDH[6>AJVZ08$^*,+-;2EE:
MVC,[>V9G#T%VG_8/O,_1UZ]IC4GP+$2?6=LR@IF?__0^8;5H\KTD9NSY6SO?
M-7EM;OLO[S+"9Z:&!'=\ $RMB^(T *-@'R%FS^+^,YT]#)W]+%3UCW"*7HR*
M]O]$,O*GH*V?EX?!J+Z3@/E/06@_"UF)9I]XOV.7/ 1<_H#I/[YWMO\D&;+?
MNR=V\SD_]CZU)=@?RCL+" G>XF?/E/8PE/:ST-7Y.A!3& >3<L'2DV7Z_PS4
M]:/QL>WE*6,I*/Q/059W3:%Y1,)2VN$=::MM0#7:SZ /RP1],*@/[4?$^X A
MO/WR[KC;_7)T[KT_/SKR_D#LH<\?O+/ST^[9T<'%E^Y1UT-(DH<"I5@NN(2%
M6E%&MRBC7]BTHY@F49GW=Z^)26JV9P%N5@^HP9%PV*-:?"8T[*/RJNZVS=)M
M-2^P'U3EP,ZOMV''M^+_[ZF7Q 4VB^E>A6'A$WKGP#L,^^&H%V8\ZI<^8BEL
M^-(DF]'9[2[>N3>,8KAM/,GR29!05]5SQ,%YL;UM-\*UXQW258K1BQA U$'0
M.;8Q=!ATW; PQ<">^==R^=>3,;"S\V,\TQXLVB>O^_'HZ,(>R?,>WW>/WQ[#
M66\\HM1>:O;&/]RPLC#T_A!<JK,LI;Y>DWP6(WK2\6)CO[S(N T1=6RBO('/
MZ?IK[^W[T\\7>NNOHB)<R\=!/WR=I#=9 )Q]>WM[;6M[;V=C]^UO>.V[QYZ*
M=>3J.P3,8P /-!ALX)=%?:0!(XU NNYLOE$DX-UB]Q],SSI^]Q^6A>!MKF\#
M1U#@\20.O<%$H(=6=!,F:F_B#2<9M1:*<CR!?=T:>]9#?-/@Z3\VE3V)_VNW
M@LO++,3VB]Y8 P,%! SDW8 PQ;>$!&+7F5Q.\H)/T-8F+^*JLXJ/B%\OB^C8
M,+ ">R]W:E=@>[-QNY>BN/YH:&I;6_>$D7_Y<@Z,O#6V'PN4%"CK&&D^>[T8
MUE6S34Z/(_88!G%QY1VDV3@5CK^")U8W5N07FHZ*JTWS_I%7]3#,^UDT5HTK
MC1*_G(5^.#6HCE<S_]%,I8%SZPVV,.3L37Y0\5C/'></''BE/7 -!F?Z?8+!
MY=N- J49EIDD]];3#YDW\1(+]N8NA,.$;P4#?#OGH3,IIX5BHQ3FHXP3W7V3
MU\GD=FNN4/;N)9/+O 5[Q<+]M22X[GW!/L5Y6!2QU?;5FC2U@:3N@[KQX\&7
M[O$96=WT([9OY49^&3=W#7KQU%"%O+_=,@]=]_X(O?#;6!ITVJ]CN,'A)+F,
ML,DB=BUTFCW":J0PA"+X9GK7EE_EV6\Z'HW"001+B5T3AS!&[#J,BE0H#4)3
M[@"7PL>,NM!2WUMT&ZLE3R=%CBE)U$)T"!^SV0J;M'%MM_YCRSZ ZZ[OX:_#
MV#\A0G!43+U#6.;OGYO7G)F7GFJ5;9^2VW#GVS.7]V$OFP395 :RYS/K-0,Q
MC/>O239=S72(<)9#-ZZAO[FK6.+%_W[YEU2JCKY)$V2SFLM9R.,">W0SD\86
MM-@44SK-3I6LLR0$,.T1B $?1%< TRR\<3#E/NI#V\6+JE^&_9PFA?;)>&J7
M?,_J5]P+-59Z NR]IUJ:8U/PB-ML?@%VCS-'YXEJ$DM>9=4]"IO,BC? 'L8Z
M@YBSWXI]+>W6#&_+YDY_=VU3>5JT']K.\M)]S:4-\>:K[1?DT 9YB=OC:P3=
M'!<@#^*0&EWEYA$R*?@FQ>S7*3*8KV'A788)2CX47UGH]#AGJ4WB#V^^29U5
MRI'HMU9]&'",7^'#L>EIQ%(6^Y/FD_Y5NU68QLBXWQE<C"]#:'=N8GP3Y>$Z
MS S[(<-:QE,SFRPOT<)5"N/)KTBLDEY@?H.MX-;<9IKNMK)#=0Z5J07PX4,_
MF.3V&R*6_Z1]P-7N^A EZ1>"%B9+]'*UEIY\6F&@_FB(C5P]L.#"+$&J,LJ2
MUY_VX072+K: (XQC5BNK%B"%F1,5H]88D/?4/&+=.[O/4C:PN_PJG<3<-GX2
MT^BBK-T*!M=1GF;Y7Z_-F#*A/73^_0 JR*M7ZR_WMG\5!N4J^%5-!(Y;/,E9
MPP[SHMP5/.CW,S0'AEDZ(JW<]%.O-0^*%,[.I&BWPF]RG=] 1[-#O-^-F0:K
M^6IO;]YJ;F^V6W]I?>H@G8 M]_T3O]A.]1KW Y*)>(?G4L1/D-7R[+?6?NO'
M/*'[8=*_0K5.-0.>?O>'U9S.U][&^NX6'* OW0OR=7Q.KRV9L;W!EO1#F\UP
M;#?,@.A$UP]H<X<LZHV_*KO7Q,33513%GT@/XC]1(_@S"N/!#T5K<T/@KUZM
M;6W_[S=BE3F7FY?NV3H(70@TO/OBUT<@TLW;S&1S]RXS>;6U^ZN'/5K^JB3>
M!<,I($7W!^><_WOWI=<+\@@LMQ34>+ [@0Y?_KKZP!J/I>+ &%[M5,;P:H?'
M\%<D'N)Y2#O*/?U#40PHR=O,IQZ8/N2%[1:JQ[N__E6IX5@9SV?BE_PQ8A4V
M273#410DR80<7&GBE0((FV3[ERW^?CJ"Z;(+M'H+J6R;ZQX&.K5[81Q,L>D;
M7-]NU=_ [C5V,X3+]DMX<]T2/H?G\$'_L>UO;K[P=_:VX;RL>UUTNZGWZG'E
M5P'[#L<!T%-ORJ[0BML-UUJXY?H/XOFP]8PYY+%7)8\]FSS:K7(X>4^HXZ_*
M$LY#=&C_@(S W=G=RL;N/J9ZZPYF<[LRFLWMORH!G5(NDVH>>1X.PA%]HTRP
M]#K*HQ_!(_?VBY.@].7=:W2D<X3AOR9)6(J5KV"H:00/O"H%=48J$0"C;ZO^
M?--G%'P-UVZNTC@4HZ;=ZB.O#@J*HE!$1:(KEUB0'&847$/W(;QU$.5]=/)B
M.CIW7?:N@WA"MR@S@4U?=J!ON@KPNG?*T4C*"JG.$^M44*21,,01T6?>8HHK
MAE[X+V"W.'L>$LN1&<D[EJ212$XO)-[+;PH'/XK@(8HQ"0H.Q;AN&$ELH*PD
MC"B6Z*;=6@[A>$]%-_6SG4\[[=:=B4>M.Q./Y]#.7Y'/'G!H'>9_ #=D:;P<
MADJ9;_TP*X((_M7OZ/,[/ K92B8C)_558M"X>4B)&!^F_#$*]HIBZ<2E@3SS
M*R:$"N?85)L?93.V_R\9M)U[SO\+3QSOXWZ:?ET[GR0)T#Q_\RE(8'09RE=V
MG7WG8G:_<WYPTOFSZQUTSHXO.B?>\>>#,L-?]CL_G)X<?NI\]KJ=@X]="W*A
MW3HXU4UB'_#]W"_T]/P#CN'HX M6%!]U'^'%U$Q2UOE3Y_P?1Q==O]VZ[7OO
MD#-\_N6X>V'-U=?;_%.>X(-T[8<[IZ?O.[4;^(#O/(!7?3@__7+F?3@YW3<T
MVV[AR[V'?OOYT>$Q;".0;O?(/J<.>MD##N#3\?_Y\O'4>G.[9?5^>L 7_X$!
M<.]]Y_S#J;/E#__FD]/3LS*'NCV#NL-24Q,1L\6=3T?GQP>=[F-0.3>4Z'S&
M0E%XW^]'W8M/1Y^),S_"V]\?O[_XZ%U\/#X_?.SC3=CS[EXK$GO("J!NY_-%
MY_/AT;FUV/;>/\+,&:;Z^!__<$^W4-VC+#ZA&,,Y/_U<T0@>X9PSI"UN0^?\
ML-T"ZO^'=_;@;_W'T9]XSBI$]PC+?7%8D2"/P=>$HCY[OQ]=')UW/G<]DJ<:
M'_$AE>SSH\Z%AVE4[X\/K,D_M!\6P=2.CDXZ7VS-'I3"$IC:<U;;<U;;0[IG
MJ!SP\P2]8-^_K]L)LF_M[NYL>(>?7CUBG(Y?VFX=_O=?-C6-U+SW4K%YS!6;
M%\$W=-_AN[@$_OLGE??HY/7RR6@4F&J4$7J3L<BTJ2RU[TP2L:[":P'*P?O3
MFP2.R54TID#9(,K':1ZIFGBK4BH/0P:[0F_U),= DE5ZU _8E<Q5OHNMMQ1O
M2['+&0PL&D4)3LV"R^E.QF-5F8)9 =;;>V&<WF!1V"B4^4S&5&:%$\GU?5S[
MHE9MT;=Q@D .]_7^R66Y'!F@@F.\M9#UQ.O0=XJXM/)5'E*>/Q<!9V&4P-!Y
ML4.LCN,X0-U$<-=@A7*ZB*J([S1VO_X%L"2PT[ K7'NE"0$OC--\DH4U;VBW
MZC?C2>)"=X@D'K_[;]Z<<."=A^DX1'?M.J(-$#F)(QU3,Y)!SJ5-(4=J[ )Q
M]J;#(W _>U//U+S;N%.!D/^_]!LS]4:A=5637U,7_GZ!RG+?&X2]PL-ZQFQ"
MG0_5,&#C J_FO52C9_)@>EQRI\9!Q$Q/P!G1G-,LNB3PO/*;5)$B59;A&M$I
M&1"&1H]'0'7K\/S@,@O&5Y7*_=(:JN!%*4NG-"Y]H$O?<]2"1UVWGC\*I ,0
MZ%R7)1S'M6.!=5#AQ8XD%:D\LG5"T.AX8^ [$69*R1;S.E&B4;7 1>]!$,=I
MGV*#L TZ3XEJ;)VLJ;H\*=^-N=.&E5Z#1"B$2E@0<V?,YV@,\XY*\RXG4VG<
MB&.8<T EH81^0=PS '85\;SH:.E@:A9>3F+FUKZW"*9#->RF^80ST1R)&,]=
M+PP3'7KCM5>A-BY=3N'R)"UTUAK&B>>N2\V*T*R=)8&UJ(3U<0=R86Y8JTJD
MP:2BF('>]BSLA]$UXWG@#\,HRPLG'8^//FZT#ALNM*V+;*BIMN:Q4M'R(E71
M20K',OB&NZV>G87%)-,3+,U7QT6M(T); TS,.0_+FYJ&*,&-+T_1*E#7-_ .
MN% E2A[#%L&%V. OS?+:"ENB8"JRQ:Q"C.-2O?3R)K1ND'O^FH;#.<'"YO]K
M.:;!_T5FG7".5CSU3D&)A-W_?W=>.+- VT^Q0,[K[X.NOE6'KKYU%W3U__6?
M?]O;?+7S!O[9VMA4_PCBTVNO8^,;9 SY&S$;QH083CX=," ::DN3J=]NY2$<
M6&#?5VD\L._'PSPBE #+2("G<)(=WH$R:) %-X&3"$2DM/]N76'_V6X2[11[
MQK$VSJ07,Z&JWW:_U*S5WLZO;[SK$!A^/XC7R#'WFL[@YMO?X(9;PU;?AK1O
M0;%OO-)LZOO-(9$BOP5!5;"J'8'J3SJ+19"#D'+0<\LL=Q%)Z'$?@8PIQ>\@
M'8V1)A5B-=(RG@2Z^P:>&?I(V*S?^X*_8><3 86/L[2/=J.5O&Y?(1!:I$9F
MH38 $' $#U,=S$4)UZ-A/3B#7J1HVH/M)3F*&?MD_*N??7LV<)27-ATY^.49
M@5E#""76:[.\89XSI\;96S079#\EO#?D6\J.0TI =87M,1@% HLA0E@T$(=-
MZ;W/B.,/"/?[19(#B7#F.YGLW@4-@9FEH-42<F!"'G%&^<DBQOM)+) [XTH@
MOZ#@SZ&!@F:3,@'3)%3WKX#>*LXC<]_<2:^23GV3RE/@6(K32V"19D+9X8F8
MA:K+3L*9CU@,-;'&0[,D9,)V:QXTH?/6QT,F;"BZJKAQFLJVYE5AM5L_;!G6
MO< ;VZUEH#=Z)?!&V2[8]A$KK M[MJ.\['-C6ASX'MASHPEZMG,/_X5!YFC>
M^<H,%O]U0+,-]:(%@T'$9HUA+>U6DFIY\X! W._^"$D:*S9%"?6A_&U!9\[,
M8[\(264Z):DK'A/Q.<Z^,0R L@RA;$N]'A'DCO4D^+AGZP\W/&BM6LCFV>,@
M;Q(#?D6W8*\S%WQO*3[U_7>GQ#3/0_&A747C'!6(6:CKN\L28P973[N:Y2AG
MX3@.^J'EM#)7&)WX*@SH[$FH2BEJ[*3?V7Q3,S?QWC]T=M2B6_SZ+F?*-JY?
M_'K;R"/P:F!C6,:"G #^]76E@E"_H_$"R?_&WN8H0\M%^:N <41Q1,8(,9Y!
M!%9W@<R4Y(#^&":7 3$D99CP%^H0#"<%J.D^&4+D 5,1.WPI6?%9'Z5;#Y1J
M<G@91$&1@9.<!";C.\(CISP>Y?KTD8O >[$0BKZ!Z8)D2BD,!R\8A_ \?)P/
MXE:..$KI),=G1*/>),OE-.X'63]&:#_5[!F;//O>?CKL6("-/GU-S_D A@0L
MNM<%UE)N2HAI-"P0 K3:V.8+<:B<T:Q]_ XC*8<?T>JKVS6U8^V6M4_I3:*T
M1&7'D7HC+@]YCLNX:$%QVPK^FJ*8_! [7D;<.<Q&>>U3P!+T1J%265%,]E*T
ME. #TPFZ/=%72[4N49^O(SL*_I7NM#;&O4^PB6IF]-!$*7SMEKT2\.K&*YTE
M@WW$7#XPT4  E[IY4\Z33R/L<Z>,W+O(@(I"H";5;85MO+-@2NK/)8EG5_^N
M\/-[.(3>]I5M9QX'^E*X!KM^>56\WEW?F/=$?&4/[/,PTS&O]0UTA8#E"5K4
MWS;H_]ZP1;9EMR!#JU/>_Y#J@.P"7#T0XIJ@=8(:)%!@NS4(AS!CCD+"4FM]
M'9,(R'L"&EV8"'F.EB-VES(Q$+M6Q/I*-R=#SZ75NB?7K7M6C&(=M%MC,VHD
MN;$U(>NGW#+3M+'0/3K0C$6;A;! BGM&.3'=22(9$-Q/#76_?490G:838=0^
M_2W!"@;3H2#E[<;&NQ(4#3-GL4&.&-COM"^A\J)N]2J3'.& D<7'8>$JV(P2
M;#V%541+W5_W_H39(>.[#.E*$ ?F_?CT(7J=0&M&)S$QA:/##YUS967A&&["
M'OQ$19KB*<80\9=W-S<WZWG87[],K]EK(-UC]M\!MQ(L6*!<=)K!$K=;.(JT
M1Q(Z@/F,-<LO+39_-6_!R5BK%64X&ZQU99J(XS6:XMSPTN;:WM[>VN[&]MK.
MWHN7OHHPS15^I;=YUMMF1@?G#FB1$>_NKKUXN;FVM;.UJTN'[']0@G*!69I=
MXBR,<[8T]CZ,'<4G[O*]1[8(9/3:UN;6VM[VB[47.V 1UX_^$=HF(;UV0&0>
M'G</3CK'GX[.N][IN7=Z\?'HW/M\>G%\<-3U+CYV+KQ/G3^]SMG9$9R._:.3
MTS^\SOD17H%?GAP?4%CCXA2K)[I8._CITY?/\"VU^NI\/O2Z'T^_G!S"K?BJ
M\R,X9(='A^M>]\O!Q]DO_^,(WM/Y<G'Z"1YVT#DY^=/[</3YZ+QS<73H=;J@
ME)P?=;^<7'BG[^GEGOON_2-L]]?%NH;?CSO>_LGIZ:?]H_,/^*+.9W[5T:?.
M\8G7_;-[<?1I_;D?X#(;V1W]S\?C_6,@DGG]WK9>/)@'N O?8>)]!T_ME_WN
M\>%QY_RXN5/MTL]8AW4>=#1*X,'8N*!D9J'EOV0KN L;1@F,P.J[$Q! @RA
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M+?[C\)5'6AXJYH,C^4(4)V2GE'499N#[<205C;U9SB BGU)O6>L1F;#Q67O
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MM^-<?OGSX9]O_H8??S]]=_SJ/U!+ P04    " !OAHE1LR*%D6P%   &!@
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MZD,]R<"$27ZR0SS:)/_L]]I))OH#4$L! A0#%     @ ;X:)45=&']5= P
M_0L  !               ( !     &-V<RTR,#(P,3(P-RYX<V102P$"% ,4
M    " !OAHE1W$)M^60&  !)1   %               @ &+ P  8W9S+3(P
M,C Q,C W7VQA8BYX;6Q02P$"% ,4    " !OAHE1*,'P6+<$  #L*@  %
M            @ $A"@  8W9S+3(P,C Q,C W7W!R92YX;6Q02P$"% ,4
M" !OAHE1FB '-V(1  !+<@  #0              @ $*#P  9#0X,#@Q9#AK
M+FAT;5!+ 0(4 Q0    ( &^&B5%S5UELE'L  */! @ /              "
M 9<@  !D-#@P.#%D97@Q,2YH=&U02P$"% ,4    " !OAHE1LR*%D6P%   &
M!@  &               @ %8G   9S0X,#@Q9S$R,#@R,S$S,C(V.3$N:G!G
64$L%!@     &  8 @ $  /JA      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
